The effect of vitamin B-6 deficiency on the bioavailability of zinc in the rat. by Moodley, Dhanabaikum.
rTHE EFFECT OF VITAMIN B-6 DEFICIENCY ON
').eO
THE BIOAVAILABILITY OF ZINC IN THE RAT ~
~y
DHANABAIKUM MOODLEY 76'
Submitted in part fulfilment of the requirements for the degree
~
of Magister Scientiae in the De artment of Human
Physiological Chemistry in the Faculty of Science at the
University of Ourban-Westville ~ ~ .
supervisor: Professor F.J. Burger
Date submitted: December .1990 .~_.,.
2 . 1 .
2.1.1.













2. 1 . 3 . 2 . Vi t am i n B- 6 and try pto Pha n-
niacin metabolism
2.1.3.3. Desu1fhydration and transul-
furation reactions
2.1.3.4. Vitamin B-6 and nonoxidative
decarboxylation reactions -
GABA a~~ s~rotoni'n synthesis


















2 . 1 . 4 .
2 . 1 .5.
2 • 1 . 6 •
2 . 2 .
2.2.1.
2 . 2 .2.
2 . 2 .3.
2.2.3.1.
2 . 2 . 3 .2.
2 . 2 . 3 .3.
2.2.3.4.
2 . 2 . 3 . 5 .
2 . 2 . 3 .6.
Biosynthesis of porphyrins
and heme
Vitamin B-6 and glucose
homeostasis
Vitamin B-6 and lipid
metabolism
Steroid function
Manifestation of vitamin B-6
deficiency in animals
Assessment of vitamin B-6
nutritional status





Biological function of zinc
Metabolism of zinc
Zinc absorption
Plasma transport of zinc



























2 • 5 • 1 •
2 . 5 .2.
2 . 5 .3.
2.5.4.
2 . 5 .6.
Manifestion of zinc deficiency
in humans and animals
The effect of vitamin 8-6
deficiency on tissue zinc levels
Zinc absorption as affected by








affected by dietary zinc levels
Experimental approaches in
















3 • 1 •
3 • 2 •
3 • 2 • 1 •






3 . 2 .2.




3 • 6 • 1 •
3 . 6 . 2 .
3 • 7 •
3 • 7 • 1 •
3.7.1.1.
3.7.1.2.
3 . 7 .2.









High performance liquid chroma-
tography - Analysis of plasma
PL and PLP
General principles of HPLC
Determination of plasma PLP








General principles of FAAS

























4 . 1 . The effect of vitamin 8-6 94
deficiency on food consumption
4 . 2 . The effect of vitamin 8-6 98
deficiency on growth
4 . 3 . Effect of vitamin B-6 deficiency 102
on plasma PL and PLP levels











Food consumption and growth






5 .5. Zinc bioavai1abi1ity as





















Biochemical structures of the
various forms of vitamin B-6
Interconverion of vitamin B-6
compounds
Typical transamination reaction
involving pyridoxal phosphate as
coenzyme
Pathway of tryptophan metabolism
showing major metabolites and













FIG. 7: The role of vitamin B-6 in the 15
synthesis of norepinephrine and
epinephrine
FIG. 8: The role of vitamin B-6 in heme 16
synthesis
FIG. 9: Basic aspects of mammalian zinc 33
metabolism
FIG. 10: Proposed mechanism for the degra- 38
dation of intestinal zinc absorp
tion
FIG. 11: Metabolism of tryptophan to pico- 55
1inic acid
FIG. 12: Vitamin B-6 and food consumption 96
FIG. 13: Vitamin B-6 and growth 101
FIG. 14: Plasma PL and PLP levels 104
LIST OF TABLES
PAGE
Table 1: Some mammalian zinc metallo-
enzymes
28
Table 2: The effect of vitamin B-6 deficiency 95
on weekly food consumption
Table 3: Two-tailed P-values - Effect of 97
vitamin B-6 deficiency on weekly
food consumption
Table 4: The effect of vitamin B-6 99
deficiency on growth
Table 5: The effect of vitamin B-6 100
deficiency on body mass
Table 6: The effect of vitamin B-6 103
deficiency on plasma PL and
PLP levels
Table 7: Percentage of zinc recovered after 105
digestion
Table 8: Mean of zinc levels in tibias 107
CHAPTER ONE
INTRODUCTION
A large portion of modern nutrition research is
concerned with the absorption and utilization of
nutrients. The term bioavailability is used to describe
these properties of foods. Although the concept of
bioavailability applies to all nutrients, investigators
are at present showing particular interest in the
bioavailability of trace elements since a number of
factors affect their absorption and assimilation.
The trace element of interest in the present study is
zinc (Zn). Zn is one of the most extensively studied
trace elements and has been long recognized as an
essential nutrient for normal growth and physiological
functioning. In fact, Zn is known to be an essential
co-factor in at least a hundred enzymes (Peereboom,
1985).
Another nutrient that has been very widely researched is
vitamin 8-6. The biologically active form of vitamin
8-6, pyridoxal-5-phosphate, is known to participate in
over a hundred different enzymatic reactions involved in
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carbohydrate me.tabolism, lipid metabolism, immune func-
tion, amino acid metabolism, gluconeogenesis, steroid
hormone action, and nervous system function.
Since both Zn and vitamin B-6 are known to participate
in a great variety of enzymatic systems, interactions
between these two nutrients would be expected. It has,
in fact, been noted that many symptoms of zinc
deficiency and vitamin B-6 deficiency are simi lar
these include impairment of food consumption and growth,
dermatological lesions, and impaired immune function
(Brown, 1981).
The effect of vitamin B-6 deficiency on the Zn levels of
various tissues has been researched. However; much
controversy exists with regard to the various results
obtained. Both increased and decreased levels of tissue
Zn concentration have been reported in vitamin B-6
deficiency (Hsu, 1965; Gershoff, 1967). No studies
pertaining to the effect of vitamin B-6 deficiency on
the bioavailability of Zn could be found in the
literature.
For these reasons, the present study was undertaken to
determine the effect of vitamin B-6 deficiency on the Zn
bioavailability in rats.
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Var i 0 us s t udie s de a1i ng wit h the ef f ec t 0 f di f fer e nt
dietary Zn levels on Zn bioavailability have been done.
Slope-ratio techniques using femur and tibia Zn concen-
trations have shown conclusively that diet~ry Zn levels
affects bone Zn concentrations and body weight
(Momcilovic et al, 1975; Stuart et al, 1986).
Tibia Zn concentrations and growth were chosen in the
present study as parameters to determine the effect of a





2 . 1. Vi t am i n B- 6
Vi t am i n B- 6 ( PYrid 0 xi ne) i s the nam e whi chi sus e d to
describe the major forms of 3-hydroxy-5-hydroxymethyl-2-
methyl pyridin,e namely pyridoxine (PN), pyridoxal (PL) and
pyridoxamine (PM). Vitamin 8-6 is classified as a water
sol ub1e vi t am i n and i s ge nera 11y f 0 und b0 un d top rot e ins
in biological materials.
2 . 1 . 1 . Chemistry
The three naturally occurring forms of vitamin 8-6 are
pyridoxine (new terminology pyridoxol), pyridoxal and
pyridoxamine (Driskell, 1984). The structure of these
three vitamins forms, along with those of the coenzymes
pyridoxal phosphate and pyridoxamine phosphate are shown
in Figure 1. The various forms of the vitamin are water
soluble and fairly stable in acids and dry heat but not in
moist heat. They are unstable in visible and ultraviolent
light, particularly when in neutral or alkaline solutions
(Shideler, 1983).
The 8-6 vitamin forms are interconvertible in animal




pyridoxine~ Pyridoxine-5- .. Pyridoxa1-5-~ Pyridoxami ne-5-
PN (d) Phosphate Phosphate (c) Phosphate
(PNP) (PLP) (PMP)
(e)
(d) t (a) (d) t (a)
Pyridoxic .- Pyridoxal PyridoxamineAcid (PL) (PM)
The enzymes involved are:
( a ) PL kinase
( b ) PNP oxidase
(c ) aminotransferase
(d ) phosphatase, and
(e ) PL oxidase; aldehyde dehydrogenase.
FIG. 2: Interconversion of vitamin 8-6 compounds.
Pyridoxine hydrochloride (PN. He 1 ) , the commonly
available synthetic form of vitamin B-6, is easily
crystallizable, odourless and has a melting point of
206°C. PN.HCl is the form of the vitamin typically used
in nutrient supplements and animal diets. The hydro-











H cJL..J 03 M
Pyridoxal ph(j.~phate
CH2NH2 0-H00CH! -o-~-o-I 11
H3C N~ 0
Pyridoxamine phosphate
FIG. 1: Biochemical structures of the various forms of
vitamin B-6.
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2 . 1 . 2 . Metabolism of vitamin B-6
Vitamin B-6 absorption occurs primari ly in the jejunum
but also in the ileum by passive diffusion (Rutishauser,
1982). Absorption in the colon is very slight. Before
absorption occurs, PLP is hydrolysed to PL and PMP to
PM. The hydrolysis occurs in the intestinal lumen and is
catalysed by intestinal phosphatases. PL, PM and PN are
then absorbed (Ink, 1984).
Although interconversion of the three forms of vitamin
B- 6 0 c cur sin the i nt est i na 1 e-e 11, the prim a r y for ms
which leave the intestinal cell and are transported to
the liver are the forms which are initially absorbed.
The liver is the primary organ for the interconversion
and metabolism of the three forms of vitamin B-6.
(Leklem, 1988). The metabolic steps involved are shown
in Figure 2.
Pyridoxal is thought to be the circulating form used by
most tissues. PL concentration in plasma is regulated by
some binding by serum albumin but also by tighter
binding to haemoglobin inside the erythrocyte
(Henderson, 1985). PL uptake is by passive diffusion
followed by phosphorylation. The liver is considered to
be responsible for the synthesis of PLP found in plasma.
PLP in circulation is bound primarily to albumin, a
- 7 -
mechanism which protects the PLP from hydrolysis and
also permits delivery of PLP to other tissues. The PLP
which is bound to glycogen phosphorylase of muscle
represents the major body pool of vitamin B-6. The major
vitamin B-6 excretory product is 4-pyridoxic acid which
is formed from PL by the action of aldehyde oxidase or
by the action of a NAD dependent aldehyde dehydrogenase
(Ink, 1984).
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2 . 1 .3. Biochemical functions of vitamin B-6
The principal active form of vitamin B-6 is PLP. PLP is
attached to an £' -ami no group of the apoenzyme vi a a
Schiff base linkage and is known to participate in a
wide range of enzymatic reactions including:
2 . 1 . 3 . 1. Tran s am i nat ion rea c t ion s
Transamination reactions are catalysed by am i no-
transferases. These enzymes are involved in the
interconversions of a pair of amino acids into their
corresponding ketoacids; generally these are C(- amino
and c(-ketoacids. PLP is converted to pyridoxamine-5-
phosphate in the process of acquiring the amino group,
and is then converted back to PLP when the amino group
is attached to a ketoacid, which then becomes an amino
acid. Each aminotransferase is specific for the
specified pair of amino and keto acids functioning as
substrates, but is non-specific for the other pair. Most
of the amino acids are substrates for transamination
reactions (Driskell, 1984). A typical transamination






































2.1.3.2. Vitamin B-6 and tryptophan - niacin
metabolism
The invol vement of vitamin B-6 in the conversion of
tryptophan to niacin is one of the most extensively
studied vitamin B-6 amino acid interrelationships. This
in part is related to the use of the tryptophan load
test to assess vitamin B-6 status (Leklem, 1988). There
is only one step in the conversion of tryptophan to
niacin which is a PLP requiring step viz. the
kynureninase step. This enzyme catalyses the conversion
of 3-hydroxykynurenine to 3-hydroxyanthranilic acid.
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FIG. 4: Pathway of tryptophan metabolism showing major
metabolites and sites of action of vitamin B-6
as pyridoxal phosphate. The large arrows
indicate the pathway for degradation of the
majority of ingested tryptophan.
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2.1.3.3. Desulfhydration and transulfuration reactions
PLP is required as a coenzyme by enzymes involved in the
metabolism of the nutritionally essential amino acid
methionine, from which adequate amounts of cysteine is
biosynthesised via the transulfuration reaction. The
enzyme involved in this pathway is transulfurase (PLP
dependent).
Desulfhydration of cysteine and homoserine requires the
interaction of PLP. These amino acids are degraded to
either pyruvate or 2-oxobutyrate + NH 3 + H2S. The enzyme
involved in the degradation to pyruvate is desulfurase a
PLP dependent enzyme.
Desulfhydration and transulfuration reactions are








Pyruvic acid + H
2
S + NH 3
•
Citric acid cycle etc.




2.1.3.4. VitaminB-6 and nonoxidative decarboxylation
reactions - GABA and serotonin synthesis
PLP is involved as coenzyme in nonoxidative decar-
boxylation reactions. Decarboxylases function in the
systhesis of ~ -aminobutyric acid (GABA) and serotonin.
PLP is required in the brain for the decarboxylation
(glutamate decarboxylase) of glutamic acid to GABA,
which is further metabolized to succinic acid. GABA is
involved in the regulation of synaptic transmission in
the nervous system. The degradation of GABA involves its




Serotonin is synthesised by the action of tryptophan





PLP +- (tryptophan decarboxylase)
Serotonin
FIG. 6: Role of PLP in the synthesis of serotonin.
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Serotonin is a potent vasoconstrictor and a stimulator
of smooth muscle contraction and it also functions in a
similar way in the brain (Driskell, 1984).
2.1.3.5. Synthesis of epinephrine and norepinephrine
PLP - dependent enzymes are involved in the synthesis of
epinephrine and norepinephrine from either phenylalanine
or tyrosine (Sauberlich, 1985). Tyrosine is decar-
boxylated by the PLP - containing tyrosine decarboxylase
to form 3,4-dihydrophenylalanine (DOPA). Under the
i nfl uence of the same enzyme 3,4-dihydroxyphenyl
ethyl amine (dopamine) is formed. Dopamine is then
converted to norepinephrine and epinephrine as shown in
Figure 7.
2 Tyrosine
(0 2 + Fe +) ~ (Tyrosine hydroxylase)
3,4-Dihydroxyphenylalanine (DOPA)
PLP ~ (DOPA decarboxylase)
3,4-Dihydroxyphenyl ethyl amine (Dopamine)
(02+ ascorbic acid) ~ (Dopamine ~-oxidase)
Norepinephrine
(S - adenosyl methionine)~ (Phenyl ethanolamine
N-methyl transferase)
Epinephrine
FIG. 7: Role of Vitamin B-6 in the synthesis of nor-
epinephrine and epinephrine.
Both norepinephrine and epinephrine are involved in
- 15 -
Porphobilinogen
carbohydrate metabolism and in other reactions in the
body (Driskell, 1984).
2.1.3.6. Biosynthesis of porphyrins and heme
The first step in the biosynthesis of porphyrins is the
condensation of glycine and succinyl CoA to form
d-amino-levulinate (ALA). This reaction i s catalyzed by
J-aminolevulinate synthase, a PLP enzyme i n the
mitochondria. This enzyme converts glycine and succinate
t 0 ex -ami n0 -0 - ket 0 ad i pi c acid, whi c h the n 10 s e s CO
2
t 0
form ALA, which in turn is converted to protoporphyrin
and heme (Stryer, 1975) as illustrated in Figure 8.
PLP











FIG. 8: The role of vitamin B-6 in heme synthesis.
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2.1.3.7. Vitamin 6-6 and glucose homeostasis
Glycogen phosphorylase, a PLP-dependent enzyme, is
involved in glucose homoeostasis. A deficiency of
vitamin 6-6 in rats was shown to result in decreased
activities of liver and muscle glycogen phosphorylase
(Leklem, 1988). Glycogen phosphorylase initiates the
catabolism of glycogen. PLP also acts as a coenzyme for
the transaminase enzyme involved in gluconeogenesis.
2.1.3.8. Vitamin 6-6 and lipid metabolism
Although it is known that vitamin B-6 is involved in
lipid metabolism, its mechanism of action has not yet
been established. The carcasses of animals deficient in
the vitamin contain less lipid than those of controls;
fatty liver, dermatitis, arteriosclerosis, and elevated
plasma lipids and cholestrol levels are also symptomatic
of vitamin B-6 deficiency. It is believed that vitamin
B-6 affects lipid metabolism via its effects on hormones
(Driskell, 1984).
2.1.3.9. Steroid function
PLP has 'recently been implicated in steroid function. At
physiological concentrations, PLP was found to act
reversi bly wi th receptors for estrogen, androgen,
- 17 -
progesterone and glucocorticoids. The reaction involves
the formation of a Schiff base with a lysine residue on
the steroid receptor. It has been establ i shed that as a
result of this interaction, there is inhibition of the
binding of the steriod-receptor complex to DNA (Litwack,
et al, 1985). Several studies, involving rats, have
found that a deficiency of vitamin B-6 results in a
greater retention of steroids in the nuclear fraction of
target cells. It has been hypothesised that there would
then be increased sensitivity of the end-target cell to
the steroi d. These studi es suggest that there is a
physiological relevance to the PLP-steroid receptor
interaction (Leklem, 1988).
From all of the above, it is clear that vitamin B-6 is
involved in a wide variety of biochemical reactions.
- 18 -
2 . 1 .4. Manifestation of vitamin B-6 deficiency in
animals
Vitamin B-6 has proved to be an essential growth factor
for all species of animals studied to date. The exact
manifestations of vitamin B-6 deficiency may vary from
one species to another but the main effects are:-
- Loss of appetite, poor food utilization, poor weight
gain or weight loss and muscular weakness (Rutis-
hauser, 1982).
- Symmetrical scaling dermatitis (acrodynia) on the




Nerve degeneration leading to convulsive seizures and
neuronal dysfunction followed by death.
- Decreased reproductive performance of both males and
females.
- A brown secretion around the eyes and a flow of tears
with weakening of vision until complete blindness is
reached.
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Other symptoms observed include fatty liver, arterio-
sclerotic lesions in rhesus monkeys, oedema, behavioural
alterations, insulin insufficiency, altered plasma
cholesterol levels and hypertension in the adult rat
(Dakshinamurti and Pau1ose, 1988).
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2 . 1 • 5 • Assessment of vitamin B-6 nutritional status
Several biochemical procedures have been developed and
utilized for the assessment of vitamin B-6 status of
humans and of other animal s. There is however much
di sag re em en t am 0 ngin ve s t i gat 0 r sas tow hi ch par am et e r
is the best criterion to assess vitamin B-6 status. The
various techniques used include the following:
The measurement of xanthurenic acid excretion following
a tryptophan load. Vi tami n B-6 is requi red for the
conversion of tryptophan to the vitamin niacin, as shown
in Figure 4. Increased xanthurenic acid following a
tryptophan load is excreted by subjects who are
deficient in vitamin B-6. This method is the preferred
technique for use in population surveys (Driskell,
1984).
Another method employed to determine vitamin B-6 status
is the measurement of urinary pyridoxic acid levels.
There are various techniques available to measure
urinary pyridoxic acid. Usually fluorometric methods are
used for this analysis. Pyridoxic acid excretion
measurements are indicative of immediate dietary intakes
of the vitamin and not of body reserves. Precise 24 hour
urine collections are however difficult to obtain.
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The measurement of alanine aminotransferase (ALAT)
activity of blood was found to be more advantageous and
ass ens i t i ve a cri t e r ion 0 f vi t am i n B- 6 nut r i t ion i n
rats as the tryptophan load test. The activity of ALAT
has been reported by several investigators to decrease
in erythrocytes, leukocytes and serum of individuals
depleted of vitamin B-6. It has, however, also been
reported that the measurement of erythrocyte ALAT
activity was more indicative of vitamin B-6 nutrition
than the activity of this enzyme in whole blood, serum
or plasma (Sauberlich et al, 1972).
In recent years, plasma PLP level has been used with
increasing frequency as an indicator of vitamin B-6
status. This technique involves the direct measurement
of the active coenzyme and is reflective of tissue
levels. Lumeng et al, 1987 have reported that plasma PLP
levels rise with increasing pyridoxine intake in the
range between 0 to 100 ~g per day. It was a1 so
established that the plasma PLP levels correlate well
with the PLP content of skeletal muscle, the major
storage pool of the vitamin B-6 compounds in rats. Based
on their findings, Lumeng et al, 1978 concluded that
plasma PLP measurement is the most direct and versatile
indicator for evaluating vitamin B-6 nutritional status.
The measurement of pl asma PL and PLP 1eve1 s by hi gh
- 22 -
performance 1i qui d chromatography techni que as devi sed
by Ubbink et al, 1986 was employed in the present study
to determine vitamin B-6 status in rats.
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2 . 1 .6. Vitamin 8-6 and its interrelationship with
trace elements
Trace elements are those elements which are essential to
human and animal biological function. Most trace metals
have been shown to have substantial chemical reactivity.
Many trace metals are cofactors in enzymatic catalysis
of a great many reactions involving over half the body1s
enzymes. Metals carry out these functions through
substrate activation or by specific binding to the
enzyme itself (Fitzgerald and Tierney, 1984).
As already mentioned, the biologically active form of
vitamin B-6, PLP, is known to participate as an
activating coenzyme for over lOO enzymes (Sauberlich,
1985). The diversity of pyridoxal-5-phosphate is
illustrated by its involvement in a wide range of
functions including gluconeogenesis, amino acid
metabolism, immune function, carbohydrate metabolism,
lipid metabolism, nervous system function and steroid
hormone action. With such a broad involvement in the
biological functioning of the body, a lack of sufficient
vitamin 8-6 would be expected to have adverse conse-
quences.
Since both vitamin B-6 and trace elements are known to
participate in a great many systems, interactions
- 24 -
between certain trace elements and vitamin B-6 would be
expected. Various studies have been undertaken to
determine the effect of vitamin B-6 deficiency on
various trace elements. A few of these findings include:
- A reported elevation of iron (Fe) stores in the liver
and kidney resulting from PN deficiency (Ikeda et al,
1979). The increased Fe levels were attributed to the
fact that less Fe is incorporated into haemoglobin in
PN deficiency since PLP is involved in haemoglobin
synthesis.
- Dietary deprivation of pyridoxine was found to result
in an increased fecal excretion of 54 Mn . However, 54 Mn
levels were increased in the brain and testicles while
a reduction of injected 54 Mn was observed in the heart
and liver (Hsu, 1965).
A deficiency of vitamin B-6 in rats resulted in a
non-specific increase in the in vitro intestinal
uptake of calcium and cadmium indicating increased
tissue levels of these elements in a vitamin B-6
deficiency state (Prasad et al, 1982).
Changes in tissue concentrations of zinc (Zn) have
been reported in vitamin B-6 deficient animals. Hsu,
1965 reported decreased concentrations of Zn in
- 25 -
plasma, liver, pancreas and heart in pyridoxine
defi ci ent rats. However, Gershoff, 1967 found increased
levels of Zn in the pancreas, serum and liver of vitamin
B-6 deficient rats.
These various findings indicate a metabolic link between
PN and various trace elements. Because of the contradic-
tory findings with regard to vitamin B-6 deficiency and
ti ssue Zn level s, the present study was undertaken to
determi ne the effect of vi tami n B-6 defi ci ency on Zn
bioavailability.
Although no studies have been found in the literature
concerning vitamin B-6 deficiency and Zn bio-
availability, the various findings on the effect of PN
deficiency on tissue Zn levels would suggest a strong
likelihood that Zn bioavailability would be affected by
a vitamin B-6 deficiency.
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2.2. Zinc
2 . 2 . 1 . Early discovery
Zn does not occur naturally in a free, uncombined state.
It was discovered by accident in the fourth century A.D.
that brass was produced when a certain earth (zinc
bearing) was heated with copper. Metallic zinc was first
produced during the 13th century in India by reducing
calamine (zinc oxide plus a small percentage of ferric
oxide) with organi c substances such as wool. Ebener of
NUrnberg is reported to have recognized Zn as a discrete
element in 1509 and in 1746 Marggraf redi scovered the
metal in Europe (Halsted et al, 1974).
2 . 2 .2. Biological functions of zinc
Zinc has a great diversity of functions - greater than
for any other organic nutrient (Mills, 1989). Having
been first shown to be required for normal growth in
rats and mi ce in the 1930s, there is now no doubt that
Zn is essential for normal life in both humans and
animals (Jackson, 1989).
Zinc plays both a unique and extensive role in the
biochemistry of enzymes and other biological molecules.
This is due to certain advantageous chemical properties
of metal ions. Zn has a highly concentrated charge,
- 27 -
Z 2+n . It is also a small ion with a radiijs of O.65A. Zn
has a hi gh affi ni ty for el ectrons and is thus a very
effecti ve attacki ng group. It does not show vari abl e
valence (oxidation state change), and for this reason is
preferred over other metal ions in certain circumstances
since redox activity introduces the risk of free radical
reactions (Williams, 1989).
Over two hundred Zn dependent enzyme activities have
been identified and such enzymes occur in all phyla.
Some of those that are relevant to humans and animals
are listed in Table 1. Various studies have shown that
Zn is probably the metal most widely distributed amongst
metalloenzymes. Metal activated enzymes are subdivided
into two classes: metalloenzymes in which the metal is
firmly bound, and metal-enzyme complexes that are
readily dosspcoated and require the continuous presence
of the activating ion in the medium (Aggett, 1985).
Enzyme Role of Zinc
Alcohol dehydrogenase Catalytic and Structural
Superoxide dismutase Structural
Alkaline phosphatase Catalytic and Structural
Fructose 1,6-diphosphatase Regulatory and Structural
Amino peptidases Catalytic






Table 1: Some mammalian zinc metalloenzymes.
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A generalized theory of metalloenzyme activity in which
catalysis depends on the existence of an entatic state
has been suggested. It is postulated that binding of the
metal to the enzyme protein results in a distorted and
partial co-ordination sphere around the metal ion and
that the energy of distortion is released or transferred
to the substrate. This theory fits in with recent obser-
vations on the structure of four Zn enzymes - carbonic
anhydrase, liver alcohol dehydrogenase, thermolysin, and
carboxypeptidase. These enzymes have been shown to
possess similar active sites centred around a Zn 2+ ion
(Chesters, 1982).
Recent research has shown that Zn pl ays an important
role as a structural constituent of enzymic and
non-enzymic proteins and of polynucleotides. Zn is
believed to govern the biological functions of a wide
range of macromolecules by conferring on them both
structural and metabolic stability. The function of Zn
in alcohol dehydrogenase for example, demonstrates its
catabolic as well as organizational roles - where it is
possible to differentiate between the Zn associated with
the functional catalytically active centre and the Zn
whi ch is 1ess fi rmly bound and i nvol ved in stab i 1i zi ng
the polymeric structure of the enzyme (Mills, 1989).
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It is postulated that Zn plays a fundamental role in
protein metabolism. Zn has, in fact, been compared to an
essential amino acid since in both Zn deficiency and
deficiencies of amino acids, there is a rapid onset of
anorexia, growth retardation,
intake, raised blood ammonia
sensitivity to nitrogen
and urea concentrations,
decreased synthesis of proteins and reduced DNA/RNA
ratios (Aggett, 1985).
Recent studies strongly suggest that Zn plays a role in
gene expression. Zn has been shown to be present and to
interact with the various chromatin components, namely
DNA, RNA, hi stone and non-hi stone protei ns. The
involvement of Zn in the synthesis of DNA, DNA trans-
cription, translation of mRNA into protein and in the
proper structure and functioning of the translated
product suggests that Zn is necessary for virtually all
aspects of normal cell metabolism (C1egg et a1, 1989).
Zinc is believed to play a diverse role in the central
nervous system. It has been proposed that Zn has a
regulatory and structural role in nerve growth factor.
Neuropsychiatric features are prominent in human Zn
deficiency. These indicate a role for Zn in neural
functions such as taste, appetite control, olfactory
function, vision, and neuromuscular co-ordination
(Aggett, 1985). Also, since zinc is distributed among
- 30 -
all enzyme classes, it has a wide range of functions in
brain and neurotransmitter homeostasis (Prohaska, 1987).
Early studies have indicated a relatively high
concentration of zinc in the bone as compared to other
tissues (Hove et a1, 1938). The discovery that "Z n is
found in close proximity to the sites of calcification
and that Zn is detected exactly in the layer of
preosseous tissue whose calcification is imminent"
suggests an important biochemical role for Zn in bone
formation (Calhoun et al, 1974). It has been theorised
that Zn affects the regulatory mechanism of ossification
and that an adequate concentration of Zn is required at
the site of the bone formation as a requisite for
complete calcification. The various findings of Calhoun
et al, 1974 have led them to conclude that Zn has an
active role in bone metabolism. The exact mechanism
however remains unknown.
It has a1sob ee n po s tu 1ate d t hat Zn play san imp 0 r tan t
role in fatty acid and carbohydrate metabolism. However,
more research is needed in this field before its exact
role can be elucidated (Halstead et al, 1974).
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2.2.3. Metabolism of zinc
2.2.3.1. Zinc absorptions
Cellular uptake from the intestinal lumen
The basic aspects of Zn absorption metabolism are shown
in Figure 9. Studies to determine the site of intestinal
absorption in rats indicate that the duodenum
contributes 60%, the ileum 30%, and the jejunum 10% to
the overall absorption of Zn. Negligible absorption of
Zn occurs in the stomach, caecum and colon (Davies,
1980).
Numerous experiments have elucidated the biphasic nature
of Zn uptake by the intestine. Davies, 1980 and Smith
and Cousins, 1980 observed two phases of Zn absorption
as a function of the luminal Zn concentration. A fast
mucosal uptake phase across the brush border membrane is
followed by a slower phase which involves transport of
zinc across the basolateral membrane. The fast phase of
uptake, with increasing luminal Zn concentrations, is
postulated to represent saturability of binding sites on
the brush border membrane. At high Zn concentrations,
the membranes may become leaky and allow Zn to enter the





FIG. 9: Basic aspects of mammalian zinc metabolism.
Absorption of dietary Zn occurs from the small
intestine. Absorbed Zn is transported in portal
pl asma bound to a 1bumi n. Muscl e and bone
rep res e n t the 1a r 9est .Z n p0 0 1 s .
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Jackson et al, 1981 have also suggested that there are
two mechanisms of Zn absorption. One of these may be
induced by low dietary Zn levels. This hypothesis is
supported by the finding that Zn absorption may have a
more pronounced medi ated component in response to Zn
depletion.
Menard and Cousins, 1983 using brush border membrane
vesicles (BBMV) in their investigations regarding Zn
transport, concluded that at low Zn concentrations
(O.2mM) uptake is saturable and occurs by a carrier-
mediated process which is not energy dependent and that
at high Zn concentrations, uptake is linear indicating a
passive diffusion process.
Research carried out by Menard and Cousins, 1983 suggest
that the mechani srn of Zn transport across the brush
border of intestinal epithelial cells probably involves
interaction between the metal in a chelated form and the
membrane surface. It was proposed that a number of
specific binding ligands might fulfil this role.
The existence of a specific low molecular weight
Zn-binding 1igand was suggested by a number of
researchers (Hahn and [vans, 1973 and Schricker and
Forbes, 1978). This ligand, thought to originate from
the pancreas, was found in the intestinal wall and in
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the milk of certain species (Evans et al, 1975 and
Lonnedal et al, 1980). Evans and co-workers have
attempted to characterize this Zn-binding ligand of
pancreatic origin and have described it as picolinic
acid (PA). They maintain that during the process of
absorption, PA is secreted from the pancreas into the
intestinal lumen where a Zn-dipicolinate complex is
formed. Thi s compl ex faci 1i tates the transport of zi nc
across the intestinal cells (Evans and Johnson, 1981).
Other studies however throw doubt on claims that ligands
secreted from the pancreas play a role in Zn absorption
( 0avie s , 1980 ) . Co usin s , 1979 has em ph as i zed the
difficulty of preventing the appearance of artefacts
when attempts are made to isolate Zn-binding ligands
from the intestinal mucosa.
Metallothionein - The intracellular Zn-binding ligand
The intracellular distribution of intestinal Zn has been
extensively researched. The basic concepts involve
hypothetical pools for Zn and the distribution of the
metal to specific cellular sites for definitive
functions ego Zn to membranes for stabilization and to
metalloenzymes and intracellular binding sites as part
of regulatory mechanisms.
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The potential function of various intracellular
Zn-binding ligands in controlling zinc absorption has
been widely studied. A key role for metallothionein (MT)
in this process was suggested by Richards and Cousins,
1977. Further research has also indicated that this
intestinal protein is inducible by Zn
Inducibility was confirmed by feeding




Zn-depleted rats, whereas dietary repletion with Zn
increased MT in a dose-dependent fashion. The inducible
nature of intestinal MT led to the postulation that MT
is an integral regul atory component for Zn absorption
(Cousins, 1985).
Mucosal MT is believed to reflect dietary Zn status and
the amount of MT present in the mucosa is negatively
carrel ated to Zn absorption, thereby exerting homeo-
static control of Zn metabolism (Lonnerdal, 1989).
Studies by Richards and Cousins, 1977 have shown that
the major Zn-binding fraction in the cytosol of mucosal
cells is metallothionein. They suggest that Zn taken up
into the intestinal cells may either be transported
across the serosal membrane into the hepatic portal
blood or, become bound within the cells to MT which
prevents its transfer to the plasma. Thus, the amount of
metal-free thionein in the Zn-absorbing cells of the
mucosa may be the major determinant of the extent of Zn
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absorption.
The following model (Figure 10), postulated by Cousins,
1979 attempts to explain the mechanism of Zn absorption
at the level of the intestinal mucosal cell.
- A portion of the dietary Zn which enters the lumen of
the small intestine is transported across the mucosal
brush border membrane (shown as A in Figure 10).
- Within the intestinal cell, newly acquired cytoplasmic
Zn equilibrates with a "Z n pool" and is either shunted
into high molecular weight proteins and MT or is
transferred to the plasma (shown as B in Figure 10).
- A major portion of Zn that enters the intestinal
mucosa from the pl asma becomes bound to MT, a pheno-
menon that is di rectly rel ated to Zn status (shown as
C in Figure 10).
- Because appreciable amounts of Zn may also be secreted
into the intestinal lumen, 11 A" in Figure 10 is repre-
sented as bidirectional transport.
- 37 -
Lumen Intestinal Cell
P I as r";l




. ?olys0m es "'-(
. ~mRNP/









FIG. 10: Proposed mechanism for the regulation of intes-
tinal zinc absorption. Dash lines indicated Zn
concentrations which may signal the induction
of intestinal metallothionein biosynthesis.
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Transfer of Zn to portal circulation
Studies with isolated rat intestine (Smith and Cousins,
1980) indicate that Zn is bound to albumin as it leaves
the serosal surface of the gut wall. This finding is in
agreement wi th earl i er work by Smi th et a1, 1979 who
obtained direct evidence that albumin is the principal
portal transport protein for Zn as it leaves the intes-
tine.
2.2.3.2. Plasma transport of zinc
Only 10-20% of the Zn in whole blood is found in plasma.
The remainder is localized within the erythrocytes in
which carbonic anhydrase is the major binding site.
Approximately two-thirds of the Zn present in plasma is
bound to albumin and one-third to «2-macroglobulin
(Chesters and Will, 1981). It is believed that about
twelve proteins in human serum bind Zn in vitro. The
order of Zn binding was found to be albumin» ex 2
-macroglobulin) transferrin, with only minor binding by
other proteins (Cousins, 1989).
The a1bumi n bound Zn is frequent 1y referred to as a
loosely bound, exchangeable Zn pool and the ability of
albumin to give up bound Zn is thought to be an
essential feature of the transfer of Zn between plasma
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and tissues (Cousins, 1985).
2.2.3.3. Cellular uptake from the systemic circulation
The major tissues which contribute to the regulation of
systemic Zn are illustrated in Figure 9. Since the liver
and kidney are considered the most significant sites of
Zn metabolism, Zn uptake by the liver and kidney will be
discussed in the present study.
Hepatic uptake
Zn is transported to the hepatocytes from the intestine
bound to albumin (Cousins, 1985). Hepatic uptake of Zn
occurs rapidly after absorption. Marked fluctuations in
the dietary zinc supply cause only minimal changes in
the Zn con ten t 0 f the 1i ver, dem 0 ns t rat i ng t hat up t ake
and efflux are closely regulated (Cousins, 1989).
In early experiments to characterize Zn uptake by the
liver, it was concluded that binding or uptake followed
first-order kinetics and a passive mechanism of Zn
accumul ati~n was proposed. However, more recent experi-
ments have shown that Zn accumulation by liver cells is
temperature dependent and energy dependence and
saturable kinetics was suggested. It has subsequently
been demonstrated that Zn uptake by liver cells occurs
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by two distinct phases - the first, a fast-uptake phase,
represents initial binding to specific sites on the
plasma membrane surface. In the second phase of accumu-
lation, Zn is accrued at a much slower rate (Cousins,
1985).
A pharmacokinetic model of 65 Zn metabolism has demon-
strated that the first order mass transfer coefficient
and linear binding constant are highest for the liver.
This strongly suggests that control of plasma Zn levels
involves hepatic mechanisms (Cousins, 1989).
Kidney Uptake
The kidney has been shown to pl ay an important rol e in
Zn metabolism. Kinetic data have demonstrated that the
fi rst-order mass transfer coeffi ci ent and bi ndi ng
constants for Zn pl ace the kidney in 1ine after the
liver as a site of metabolic significance. The kidney is
therefore believed to have a substantial influence on
the plasma zinc compartment.
Renal insufficiency has been shown to result in reduced
serum Zn concentrations. This has been correlated to
increased urinary Zn bound to ligands of smaller
molecular weight than albumin.
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Hormonal regulation of renal Zn excretion has been
demonstrated. Insul in has been found to inhibit the
excretion of Zn in perfused dog kidney when added to the
vascular perfusate, while infusion of glucagon was shown
to increase Zn excretion in the same model.
The effect of renal MT on renal handl ing of Zn has not
yet been determined. It has been found, however, that
endotoxin and interleukin-l administration increases MT
mRNA levels in the kidney. These mRNA levels were found
to increase in the kidney and intestine under practical
fee din g con di t ion s , suggest i ng t hat the se 0 r gan s may
influence Zn metabolism through MT related shifts in
cellular uptake.
2.2.3.4. Body zinc store
Zinc is present in all organs, tissues and secretions of
the body. Because of the large bulk of skeletal muscle,
this tissue contains the greatest portion of body Zn.
Together wi th bone, these two ti ssues account for more
than 80% of the tota 1 body Zn. Zi nc is primari ly an
intracellular ion and intracellular Zn accounts for over
95% of the total body Zn (Jackson, 1989). Extracellular
fluids have a relatively low Zn concentration, with
plasma representing approximately 0.1% of total body Zn
in humans.
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Several researchers have accepted that an effective body
Zn store does not exi st and, therefore in all species
studied, a marked decrease in dietary Zn is followed
quickly by harmful signs of Zn deficiency ego skin
lesions, growth failure and reduced food intake (Golden,
1989). It is postul ated that si nce there is no store
from which to increase Zn supply, the body decreases its
demand for Zn by reducing food intake and therefore
growth rate.
Other researchers have, however, argued in favour of a
functional, though limited, Zn store. Various
experiments, using weanling rats, have demonstrated that
pre-treatment wi th excess di etary Zn resul ts in
increased bone zinc concentrations, while Zn-deficient
diets given to the same experimental animals resulted in
decreased bone zinc concentrations. Brown et al, 1979
showed that in weanl ing rats given a Zn-deficient diet
without pre-treatment, there was a significant fall in
femur Zn concentration despite continued femur growth.
They postulated that Zn was released from bone during
periods of dietary zinc deficiency.
2.2.3.5. Zn excretion
Zinc is excreted almost entirely via the faeces. Animal
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experiments have demonstrated that faecal excretion is
chiefly by way of the pancreatic juice regardless of the
route of Zn intake. Negligible amounts are excreted by
the liver into bile (Halsted et al, 1974). Skin, hair
and nails, being high in Zn, are also important routes
of Zn excretion. Although little Zn is excreted in the
urine, urinary Zn content does appear to respond to
large changes in body status such that overt depletion
of Zn results in a reduction in urinary Zn content
(Jackson, 1989).
2.2.3.6. Whole-body Zn homeostasis
The relatively constant levels of Zn in tissues and body
fluids in situations where the composition of the diet
varies suggests that there is an efficient mechanism for
whol e-body homeostasi s. Zn homeostasi s appears to be
maintained by manipulation of both gastrointestinal
absorption and gastrointestinal excretion of the ele-
ment. Since little Zn is excreted in~the urine, changes
in urine Zn content can contribute little to the
maintenance of whole-body homeostasis at normal dietary
Zn intakes (Jackson, 1989). Low Zn diets result in an
increase in the proportion of Zn absorbed from the diet,
but decreases in the rate of excretion of Zn into the
gastrointestinal tract are also known to occur in
response to a reduction in dietary Zn (Baer and King,
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1984). Conversely,. a reduced fractional absorption of Zn
and an increase in the rate of gastrointestinal
excretion of Zn were found to occur in response to an
elevation in dietary Zn. Thus, it is apparent that the
body is able to respond to relatively large variations
in dietary Zn so as to maintain a relatively constant
body Zn content (Jackson et al, 1984).
2 . 2 .4.
In animals
Manifestation of Zn deficiency in humans and
animals
The si gns and symptoms of Zn defi ci ency are markedly
similar in different animals. Zinc is an important
nutrient and a Zn deficiency in animals may result in
diverse symptoms, the most commonly observed of which
include dermatitis, emaciation, alopecia, ocular
lesions,
anorexia.
testicular atrophy, retarded growth and
In ruminants, parakeratosis, hair
fissures around hooves, reduced
loss, cracking and
testicular size,
decreased libido, and retarded sexual maturity are
characteristic signs of Zn deficiency. The most common
symptoms observed in birds include decreased and
abnormal feather growth, reduced egg production and
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hatchability. In sheep, Zn deficiency results in
lethargy, increased tendency to bleed, decreased immune
response, bad wound healing and poor quality of wool
(Peereboom, 1985). Zn deficiency in rats is
characterized by growth retardation, immature hair
coats, scaly feet and fissures at the corners of the
mouth (Swenerton and Hurley, 1967 and Giugliano and
Millward, 1984).
Congenital malformations have been observed in rat
fetuses delivered from Zn-deficient females. These
malformations include misshapen heads, clubbed feet,
fused or missing digits, and short lower jaws and long
bones (Halsted et al, 1974). Other skeletal defects
observed were fusion of ribs, curvature of the spinal
column, missing vertebrae in the tail and incomplete or
retarded ossification in ribs, vertebrae and cranial
bones. Malformation of internal organs including the
brain, heart, lung and urogenital system al so occurs
(Hur 1ey, 1981 ) .
In humans
In humans, the Zn store in bone and muscle is not
readily available if the oral Zn intake is not suffi-
cient. Zn deficiency may therefore easily develop. Indi-





vulnerable to marginal Zn deficiencies
1985). Marginal Zn deficiency is fairly
Western, industrialized societies and is
thought to result from inadequate dietary intake (or
availability), malabsorption and increased rates of loss
from the body. Symptoms of marginal Zn deficiency
include failure of appetite and growth, mental lethargy,
night blindness, decreased taste (hypgeusia) and skin
lesions.
Food components such as phytic acid and fibre were found
to decrease the absorption of Zn. It has al so been
observed that in diets containing a high content of
cereals, the bioavailability of Zn is poor (Peereboom,
1985). In the Middle East, some of the growth retar-
dation, skin lesions and impaired sexual development of
adolescent malnourished boys was found to be caused by
Zn deficiency. Also acrodermatitis enteropathica, with
severe skin lesions, hair loss, and diarrhoea, was
diagnosed as resulting from an inherited defect of Zn
absorption.
Clinical features of severe zinc deficiency include:
Neuropsychiatric changes, comprising a change in mood,
loss of affect and emotional lability. As the Zn
deficiency progresses, anorexia and dysfunction of
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smell and taste develop. The subjects become irri-
table, depressed and easy to anger. Signs of
cerebellar disturbances may occur, characterized by a
fine tremor and slurred speech.
- Eye abnormalities, including a mild dry conjunc-
tivitis, increased keratinization of the eyelids,
corneal oedema, and bi 1ateral cataracts.
- Dermatological features, comprising an early skin rash
involving the nostrils, corner of mouth, and chin;
hyperkeratotic lesions due to prolonged Zn deficiency;
symmetrical facial dermatitis; a papular acneiform
rash with haemorrhagic brown discoloration may develop
parakeratotic skin lesions of feet, ankles and knees.
- Growth retardation and reproductive abnormalities,
including failure to thrive, impaired weight gain,
hypogonadism, and impaired testicular development
(Aggett, 1989).
- Other symptoms of severe Zn deficiency include
impaired immune response, liver cirrhosis, impaired
wound healing, sickle-cell anaemia, epilepsy and loss
of taste and smell (Peereboom, 1985).
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2.3. The effect of vitamin B-6 deficiency on tissue
Zn levels
Although experimental work investigating the influence
of vitamin B-6 deficiency on Zn metabolism has been
undertaken by various researchers, much controversy
exists as to the various results obtained.
Hsu, 1965 found that the zinc content of plasma, liver,
pancreas and heart of PN-deficient rats was signifi-
cantly lower than that of PN-treated animals. However,
no substantial differences in Zn concentrations of the
brain, kidney and spleen were observed between the
deficient and control animals.
Gershoff, 1967 using a different experimental protocol
to determine the tissue Zn content of PN-deficient rats,
obtained results which were in disagreement with those
obta i ned by Hsu (1965). Gershoff found that PN defi-
ciency resulted in increased levels of Zn in the
pancreas, serum and kidney of rats.
Hsu' s (1965) results showed that in addition to the
decreased Zn levels observed in plasma, liver, pancreas
and heart tissues of the vitamin B-6 deficient rats,
there was an increase in injected radioactive zinc
concentration. The uptake of Zn-65 by the plasma and
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liver of PN-deficient rats was found to be significantly
higher than that of their respective controls. This
observation was in agreement with a previous study
(Hammam et al, 1965) which demonstrated that
Zn-deficient rats retained more injected radioactive
Zn-65 in their tissues than those receiving Zn supple-
mented diets. It was therefore maintained that since
PN-deficient rats showed a decrease in Zn concentration
in certain tissues, an increased uptake of administered
Zn-65 would be expected.
In the experiment performed by Gershoff, 1967, half the
rats in each group ie. the control and PN-deficient
groups, were fasted during the final 24 hours of the
experimental period. It was observed that among the fed
animals, the PN-deficient rats showed an increased level
of tissue Zn, particularly in the pancreata where the
PN-deficient rats contained over a hundred per cent more
Zn than those of the controls. Gershoff also noted that
when control rats were pair-fed or fasted for 24 hours,
there was a rise in the tissue Zn levels which was
particularly significant in the fasted rats. The effect
of fasting on Zn levels of vitamin 8-6 deficient rats
was not found to be significant. Gershoff maintained
that these findings would explain the results obtained
by Hsu, 1965 who pair-fed his rats and then fasted them
overnight before determining tissue Zn content. Gershoff
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thus concluded that Hsu's observation that PN deficiency
in rats decreased tissue Zn concentrations was to a
large extent a reflection of the high tissue levels of
Zn in his fasted control rats.
Ikeda et al, 1979 reported that there was no significant
difference in the Zn content of the liver, pancreas,
spleen, lung or testes between PN-deficient and control
rats. A significant increase in kidney Zn concentration
was however observed in the deficient group. The results
of Ikeda et al, are therefore in agreement with those of
Gershoff, 1967 with respect to the increased Zn levels
observed in the kidneys of PN-deficient rats. It will be
recalled that Gershoff reported a significant difference
in the Zn levels of various tissues of PN-deficient
animals. This difference was particularly significant in
the pancreata where the vitamin 8-6 deficient rats
contained over 100% more Zn than those of the control
animal s. The study of Ikeda et al however showed no
significant difference in Zn levels of the pancreata
between control and deficient groups.
In their paper, Ikeda et al reported that rats fed a
vitamin 8-6 diet with deoxypyridoxine injections showed
increased urinary excretion of Zn combined with
xanthurenic acid when compared to rats which were only
fed a vitamin 8-6 deficient diet. They therefore
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concluded that a more severe vitamin 8-6 deficiency (as
caused by deoxypyridoxine injections) may give rise to a
decrease in tissue Zn concentrations. If this hypothesis
were shown to be true, it would verify the results
obtained by Hsu, 1965 who reported decreased tissue Zn
concentrations in vitamin 8-6 deficient rats.
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2.4. Zinc absorption as affected by a deficiency of
vitamin B-6
Prasad et a 1, 1982 reported a si gni fi cant increase in
the uptake of Zn from the intestine of vitamin B-6
deficient rats when compared to control and pair-fed
animals. To explain their results, Prasad et al,
postulated that the lack of pyridoxine may lead to an
impairment of nucleic acid synthesis. A decrease in
nucleic acid synthesis would result in a subsequent
inhibition of protein synthesis and cell division and
repair. Since vitamin B-6, as the co-enzyme, catalyses a
variety of enzymatic reactions involved with nitrogen
metabolism, it was concluded that a significant alter-
ation could be expected in the brush border membrane
which may result in an increase in Zn uptake. These
findings would explain earlier observations by Gershoff,
1967 who reported an increased Zn content in various
tissues of PN-deficient rats.
However, various observations have been reported (Evans
et al, 1979) which contradict the findings of Gershoff
1967. Instead these observations provide an explanation
for decreased tissue concentrations resulting from a
vitamin B-6 deficiency as reported by Hsu, 1965.
Evans and Johnson, 1981 observed that a vitamin B-6
- 53 -
deficiency resulted in an impairment of
absorption. This result was attributed to
production of picolinic acid (PA).
dietary Zn
a decreased
Using a technique known as modified gel filtration
chromatography, Evans et al, 1979 obtained evidence
which suggested that the dominant Zn-binding ligand in
the rat intestine is picolinic acid (pyridine-2-
carboxylic acid), a product of tryptophan metabolism.
One of the enzymes, kynureninase, in the pathway from
tryptophan to picolinic acid requires pyridoxal as a
cofactor (see Figure 11). It was therefore maintained
that if endogenous picolinic acid facilitates dietary Zn
absorption, a deficiency of either vitamin B-6 or
tryptophan should impair Zn absorption. Evans and
Johnson (1981) subsequently also noted that both Zn
absorption and pancreatic picolinic acid concentrations
were increased as the levels of vitamin B-6 was
increased. It was further observed that supplemented PA
ameliorates the impaired Zn absorption caused by a
tryptophan or PN deficiency. From these observations,
Evans, 1980, concluded that Zn absorption is affected by
levels of both dietary tryptophan and PN and because PA
is a metabolic product of tryptophan and depends upon PN
for its production, these results provide strong
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FIG. 11 Metabolism of tryptophan to picolinic acid.
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The above observations of Evans and Johnson would also
explain the results obtained by Hsu, 1965 who found
decreased concentrations of Zn in several tissues from
rats fed a diet deficient in vitamin B-6.
The conclusion reached by Evans, 1980 has however, been
criticized by Hurley and Lonnerdal, 1980 who suggest
that the data presented by Evans and Johnson, 1980 was
not sufficient to warrant the conclusion they reached.
Hurley and Lonnerdal, 1980 maintain:
1) Picolinic acid is not a significant end product of
tryptophan metabolism in the rat and, in fact, only
7.4% of 3-hydroxyanthranilic acid (an intermediate
metabol ite of tryptophan) is converted to PA by rat
liver extracts and only 4% is converted to urinary
picolinat~ in vitro.
2) Evans and Johnson based a major part of their
conclusion on the fact that PA is a good 'chelator of
Zn. However, increasing the Zn absorption by
addition of a chelating agent does not indicate that
the chelating compound has a normal physiological
role and,
3) In their laboratory, Hurley and Lonnerdal, 1980
noted that the analysis of pancreatic fluid and
pancreatic tissue of rats showed no indication of
the presence of a low molecular weight Zn-binding
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ligand whereas the analysis of human milk did reveal
the presence of a low molecular weight Zn-binding
ligand which was identified as citrate and not PA.
Subsequent research has however produced resul ts that
favour the findings of Evans and Johnson, 1980. Krieger
and Statter, 1987 in their efforts to demonstrate the
effect of tryptophan deficiency and PA on Zn metabolism,
have shown that a tryptophan deficiency leads to low
plasma Zn levels and also low bone Zn concentrations in
rats. They concluded that their findings could not be
attributed to insufficient albumin synthesis because
tryptophan is not a building block of albumin and
because 90% of tryptophan is non-covalently bound to
albumin which seems to function as a carrier. Instead,
the low Zn levels are attributed to the fact that
tryptophan supplies the Zn carrier, namely PA, which is
a strong bidentate ligand and important in Zn
absorption.
Brown, 1985 in his article dealing with the possible
roles for vitamin B-6 and trace metals in health and
disease agrees with the findings of Evans and Johnson,
1980. His report favours the idea that PA enhances Zn
uptake and that the nutritional status of Zn may be
related to vitamin B-6 status since several studies show
that Zn uptake or tissue Zn levels in laboratory animals
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are directly related to vitamin B-6 intake.
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2.5. Zinc bioavailability
2 • 5 • 1 • Definition
There are major discrepancies in the literature as
regards the definition of bioavai 1abi 1 ity. Some
researchers have equated bioavailability with absorp-
tion. The term absorption would however lack meaning
unless it is qualified as either true or apparent
absorption. True absorption is defined as the proportion
of a nutrient in food which moves across the mucosa and
into the body, while apparent absorption is the differ-
ence between the nutrient content of the food and faeces
without reference to the immediate origin of the
nutrient in the faeces (OIDell, 1984).
In recent studies, bioavailability has been defined as
the proportion of a nutrient in food which is absorbed
and utilized (Schaafma et al, 1988). This definition is
gaining wide acceptance and is used with increasing
frequency by investigators researching trace element
bioavailability.
- 59 -
2 . 5 . 2 . Exogenous factors that affect Zn
bi 0 avail ab i 1i ty
Exogenous factors that may suppress the availability of
Zn for intestinal absorption include:
Protei n: Studi es show that a hi gh protei n di et si gni-
ficantly increases the apparent absorption of Zn and its
deposition in bone as compared _to a low protein diet
(0 I Dell, 1984). However, research has shown that more
important than the level of dietary protein, is its
source. Various studies have reported that Zn in soybean
protein is less available to animals than that in
casein. The apparent absorption of Zn by rats fed casein
was 84% compared to 44% by those fed soybean protei n.
Soybean protein caused a lower percentage absorption of
Zn from the intestine. From these findings it was
concluded that Zn in plant proteins such as isolated
soybean protein is bound so that it is absorbed less
efficiently than the Zn in animal proteins such as
casein (OIDell, 1969).
Phytate: The inhibitory effect of phytic acid on the
absorption of Zn in experimental animals was first
suggested in the early 1960s (Solomons, 1982). It was
also speculated that the dietary basis for the Zn
deficiency syndrome seen in the Middle East was the high
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phytate content of the diet. Phytate-rich bread and
purified phytate were found to reduce the apparent
absorption of dietary Zn. These findings led OIDell,
1969 to cone 1ude that phytate binds zinc and when in
sufficiently high concentrations in the diet, decreases
the availability of Zn.
Fibre: The effect of dietary fibre on Zn bioavail-
ability has been extensively studied (OIDell, 1984). The
inhibition of Zn absorption by foods rich in dietary
fibre has been shown by tolerance tests and 65 Zn
retention studies (Sanstead, 1982). 65 Zn was found to be
less readily available for intestinal absorption when
added to wholewheat bread than when added to white
bread. The poor avai 1abi 1ity of Zn from such diets was
attri buted to the bi ndi ng of Zn by fi brous components
(eg. lignin and hemicellulose) of the diet.
Calcium: Dietary calcium (Ca) levels have long been
associated with Zn bioavailability. It has however been
determi ned that the detrimenta 1 effect of hi gh Ca is
dependent on the presence of phytate in the diet
(OIDell, 1984). Zn has been found to co-precipitate with
phytate and Ca at the alkaline pH that is present in the
lumen of the small intestine.
Other exogenous components that have been shown to
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affect Zn bioavailability include oxalate, iron, copper
and cadmium.
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2 . 5 .3. Endogenous factors affecting Zn
bioavailability
Picolinic acid (PA), a product of pyridoxine-dependent
tryptophan metabolism, is secreted into the intestinal
lumen by the pancreas. PA has been shown to facilitate
Zn absorption (Evans, 1980). PA forms dipicolinate
complexes with many divalent cations. A deficiency of
picol inic acid in rats fed diets low in tryptophan or
pyridoxine was shown to impair the intestinal absorption
of Zn. Supplementation of the low tryptophan or
PN-deficient diets with PA was found to improve Zn
absorption (Evans and Johnson, 1980; Evansand Johnson,
1981 ) .
Evans, 1980 also attributed a failure of picolinic acid
synthesis to be the cause of Zn malabsorption in infants
with acrodermatitis enteropathica. These findings would




2 . 5 .4. Zinc bioavai1abi1ity as affected by dietary
Zn levels
Several studi es have reported that di etary Zn 1eve1 s
affect both tissue Zn levels and body weight. Momci1ovic
et a1, 1975, using total femur Zn as the parameter of
c h0 ice for Zn b i 0 ass ay i n rat s , r ep 0 r t e d t hat tot a 1
femur Zn and femur Zn concentrations increased with
increasing levels of zinc in the diet. Using the
slope-ratio technique to determine Zn bioavailability,
Momci lovic et al, 1975 found that dietary Zn not only
affects femur Zn levels, but body weight as well. The
body weight of rats was observed to increase with
increasing levels of dietary zinc. This latter finding
was in agreement with previous studies which also
reported that di etary Zn affects body wei ght (Ober1 eas
and Prasad, 1969; Wil1iams and Mills, 1970).
Forbes and Parker, 1977 also studying the biological
availability of Zn, reported that weight gain and total
femur Zn increased with increasing dietary Zn concen-
tration. In subsequent studies, Stuart et al, 1986 found
that total tibia Zn and tibia Zn concentrations were
higher in rats fed zinc-adequate diets than in rats fed
marginally Zn-deficient diets.
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2 . 5 .6. Experimental approaches in the assessment
of zinc bioavailability
Several techniques have been used to assess Zn bio-
availability in man and animals.
The true absorption of Zn is a frequently used technique
in studying Zn bioavailability (Hallmans et al, 1987;
Lonnerdal et al, 1984). However, it has been argued that
whi le true absorption constitutes a major component of
bioavailability, it does not measure utilization or
assimilation (OIDell, 1984).
Metabolic balance studies are often used to determine Zn
bioavailability, especially in human studies. In this
approach, the amount of Zn in the stools is subtracted
from the Zn in the diet, and an apparent absorption (not
true absorption) is calculated. The balance method has
however been found to be time consuming, tedious,
exacting and expensive (Solomons, 1982).
Radioisotopic techniques have also been used in Zn
bioavailability studies. Zn has several radioisotopes.
65 Zn has been the most widely used radioi sotope but it
has the disadvantage of having a radioactive half-life
of 245 days and a biological half-life of over 500 days
(Solomons, 1982).
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Growth rate may al so be employed as a means of deter-
mining Zn bioavailability when immature animals are used
(OIDell et al, 1972). However, the growth rate technique
cannot be used in human studies since it is not possible
in adults and cannot be ethically employed with infants
(OIDell, 1984).
Tissue concentration of Zn is often employed to
determine Zn bioavailability (Stuart et al, 1986; Forbes
and Parker, 1977; Momcilovic et al, 1975). The slope
ratio method is frequently applied in these studies and
the tibia or femur is often the tissue of choice in
studies involving rats.
Dangi and Kapoor, 1983 found that the mean femur Zn
concentrations increased significantly with increased
levels of dietary Zn and vice versa. In addition,
Golden, 1989 in his publication reported that bone was
the only tissue with an unequivocal reduction in Zn
during a zinc deficiency. Giugliano and Millward, 1984
also found that bone Zn concentrations were reduced
during a Zn deficiency in rats.
Calhoun et al, 1978 reported a significantly lower bone
Zn level in Zn deficient rats as compared to control
rats fed adequate zinc. They concluded that Zn is not
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I1 10 c ked 11 i nth e b0 ne i n you ng ani ma 1s but t hat b0 ne i n
young, growing animals serves as a Zn store and that Zn
is mobil i zed from bone duri ng Zn defi ci ency in young
animal s.
In view of the various positive reports pertaining to
bone Zn concentrations as a method to measure Zn
bioavailability, tibia Zn concentration and the growth
of animals have been chosen, in the present study, as
parameters for the assessment of Zn bioavailability as




3.1. Structure of the study
- Diet preparation for control and experimental animals.
- The induction of pyridoxine deficiency in the experi-
mental group.
- Pair-feeding of one group of animals with the
deficient group.
- Monitoring of the food consumption daily and the body
mass weekly of all rats.
- Collection of blood samples and bone (tibia) tissue at
the end of the experimental period (eight weeks).
- Biochemical determination of plasma pyridoxal and
pyridoxal-S-phosphate levels to establish the vitamin
B-6 status of all three groups.
- The drying and digestion of bones by a wet ashing
technique.
- Determination of tibia Zn levels by atomic absorption
spectrophotometry.




3 • 2 • 1 • Composition of the diet
A diet (personal communication) comprising the following













CaHP0 4 ·2H 20
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The concentrations of the various components of the salt
and vitamin mixtures were calculated and compared to the
Hawk and Oser salt mix and the ICN vitamin diet forti-
fication mixture (French, 1966). The concentrations of
the various nutrients in the present diet were found to
correlate closely with both the ICN vitamin diet forti-
fication mixture and the Hawk and Oser salt mix. The
vitamin mix in the present ~iet was also found to
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closely resemble the water soluble vitamin mix recommen-
ded for rats (Kandutsch and Baumann, 1953) ). Particular
attention was paid to the pyridoxine content in the
various diets.
The PN concentration in the present diet (2.42 mg
PN.HC1/kg diet) was found to closely approximate that in
the water soluble vitamin mix recommended for rats
(2.50 mg PN/kg diet) and was also in keeping with the
nutritional requirements for the rat as recommended by
Cuthbertson, 1957, where the pyridoxine requirement for
the rat is given as 2 mg PN/kg diet.
Also, Channa, 1988 using diets comprising 3.5 mg
PN.HC1/kg and 1.75 mg PN.HC1/kg on two separate groups
of rats found that although the 3.5 mg PN.HC1/kg diet
enabled optimal growth of rats, the growth trends
between the rats consuming the two different diets were
not significantly different. This would suggest that
1.75 mg PN.HC1/kg of diet was sufficient to sustain
normal growth in rats and that 3.5 mg PN.HC1/kg of diet
may actually be in excess of the requirements for
optimal growth of rats.
In view of the above, 2.42 mg PN.HC1/kg of diet was
chosen for use in the present study as an appropri ate
concentration of PN for optimal growth of rats.
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3 . 2 . 2 . Diet preparation
All equipment used in the preparation of the diet were
first thoroughly washed with Contrad (Merck), rinsed
several times in deionised water and then air-dried. To
avoid contamination, plastic disposable gloves (Johnson
and Johnson) were worn at all times during the diet
preparation. Only plastic spatulas were employed in
dispensing the various nutrients.
Plastic weighing boats were used in the weighing of all
nutrients which was done on an electronic balance
(Mettler BB 300). The vitamin and salt mixtures were
prepared prior to the preparation of the compl ete di et
itself. All constituents of a crystalline nature were
pulverized in a porcelain mortar until a fine powdery
consistency was achieved. A porcelain pebble-mill was
also employed to pulverize the crystal constituents that
were needed in larger quantities ego sucrose.
Two vitamin mixtures were prepared - one with and one
without pyridoxine. In the preparation of the salt and
vitamin mixtures, the compounds needed in small quanti-
ties were mixed first and then, through a number of
triturated steps, all constituents were added and
thoroughly homogenised in a large mortar. To prevent
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nutrients of a deliquescent nature from attracting
moisture, they were first mixed thoroughly with
anhydrous components of the di et and then stored in a
dessicator prior to incorporation into the diet.
After hand mixing, the vitamin and salt mixtures were
further homogenised in a mechanical mixer (Forster
Equipment Co, Eng.) for two hours. The two different
vitamin mixtures and the salt mix were then transferred
to plastic bags, properly labelled, and stored in air-
and light-tight containers until required.
The final complete diets, one with and one without
vitamin B-6, were prepared in batches of 4 kg each. This
was done twice a week for the duration of the experi-
ment. Here again, the nutrients required in smaller
quantities were mixed before adding nutrients required
in larger quantities. The dry ingredients were mixed
first and only then were the oil components of the diet
added. After hand mixing in a mortar using a pestle for
approximately two hours, the mixture was transferred to
a mechanical mixer for thorough homogenization for a
further two hours. The compl eted di ets were then di s-
pensed into plastic bags, labelled and stored in a
light-tight container at approximately 3°C.
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3.3. Induction of vitamin B-6 deficiency
Thirty-three young male Wistar rats, supplied by the
Biomedical Resource Centre (BRC), University of Durban-
Westville (UDW), were used in this study. The rats with
masses ranging from 60 to 80 g, were divided into three
groups of eleven rats each such that the mean weight of
each group was similar.
Group A, the control group, was fed the adequate diet
containing 2.42 mg/kg of vitamin B-6 in the form of
PN.HC1.
Group B, the pair-fed animals, received the same diet as
group A, but their rations were restricted to the
average amount consumed the previous week by the
deficient group.
Group C, the deficient group, was fed the PN-deficient
diet (0 mg PN/kg).
The need for a pair-fed group in the experiment was
evident since a decrease in food consumption by the
PN-deficient animals was anticipated. The pair-fed
animals were introduced into the experiment a week after
the commencement of feeding of the control and deficient
groups, thus enabl ing the determination of the average
dietary consumption of the deficient group for the week.
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The rats were housed individually in perspex metabolic
cages (Techniplast) in an air-conditioned room at the
SRC. The average humidity and temperature were 55% and
22°C respectively and automatically controlled illumi-
nation with twelve hour light and dark cycles was main-





that only the head of the
into the container while
feeding, thus minimizing food spillage and contami-
nation. The metabolic cages had stainless steel grid
floors which allowed the faeces and urine to be
separately collected in pastic containers below the
cage, to prevent coprophagy. The cages and food
containers were regularly washed with disinfectant and
rinsed with deionised water by the BRC.
Deionised water, made using an Elgastat Bl14 water
deioniser (Elga Products, England), was supplied to the
animals via water bottles attached to the cages. Both
the water and the diet were supplied ad libitum to the
animals.
Food consumptlon was recorded daily and all animals were
wei ghed once a week for the duration of the study. The
animals were also examined daily for any physical signs
of deficiency or disease. Each group of rats was main-




At the end of eight weeks, all food containers were
removed from the metabolic cages and the rats were held
overnight without food but with access to deionised
water.
All surgical procedures and sample collection were
performed on the following morning at the post-mortem
laboratory in the BRC, UOW. All surgical instruments
used were washed and rinsed in deionised water to avoid
contamination.
Rats were anaesthetised with halothane and blood samples
removed by cardiac puncture using disposable plastic
syringes and stainless steel needles. The samples were
immediately transferred to labelled 5 ml vacutest tubes
with EOTA, which were then placed in crushed ice.
After the blood was removed, the hind limbs were excised
and the tibias extracted. Tibias were cleaned of
adhering soft tissue, blotted (ashless filter paper) and
then placed individually in labelled plastic vials. All
vials were immediately placed in crushed ice before
storage at -7°C.
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3.5. Reagents and laboratoryware
Zinc is ubiquitous in the environment, and it is there-
fore important that the utmost care is taken to prevent
contamination of samples from water, glassware and
rea ge nt s . Tom i ni mi ze con t am i nat ion, all g1ass war e and
plasticware used in the experiment were first
acid-washed by soaking in 20% nitric acid for 48 hours.
Glassware and plasticware were then rinsed several times
using deionised water, thoroughly dried and stored in
plastic bags until required.
The reagents used were as follows:
Double deionised water, made using an Elgastat Bl14
water deioniser (Elga Products, England).
Zinc stock standard (Spectrosol) from BDH Chemicals,
Poole, England.
Nitric acid (suprapure) from Merck, Darmstadt, Germany.
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3.6. High Performance Liquid Chromatography (HPLC) -
Analysis of plasma PL and PLP
3 .6.1 . General principles of HPLC
The techniques of chromatography are relatively new.
"Their value lies in their versatility providing
methods not only for the separation and purification of
compounds but also for product identification and
quantitative analysis" (Doyle and Mungall, 1980).
Chromatographic methods involve the reversible transfer
of a compound that is adsorbed on a stationary phase
into a mobile phase that is flowing past the stationary
phase (Doyle and Mungall, 1980). The separation of
mixtures into their various components is due to the
difference in equilibrium distribution of these compo-
nents between two different phases.
There are various types of chromatography:
- Paper
- Gas (GC)
- Thin layer (TLC)
- Open column
- High performance liquid (HPLC)
All the above forms, except GC, are forms of liquid
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chromatography. The basic methods that apply to all
forms of liquid chromatography are as follows: liquid
chromatography comprises a stationary phase and a mobile
phase and as a result of the various affinities of the
sample for each, a separation occurs. Due to inter-
actions between sample molecules, stationary phase and
mobile phase, individual molecules are retained by the
stationary phase. The unique chemical interactions of
each component determi nes the 1ength of time for whi ch
the individual molecules are retained. Since these
interactions differ, the retention times differ and
separation is achieved.
HPLC is ordinary liquid chromatography done with sophis-
ti cated equipment. Pump's employed for HPLC are usually
desi gned to provide a constant flow and to be
pulse-free. The pump drives injected solvent under high
pressure through columns packed with an adsorbent and
t hus br i ngs ab 0 uta s pe cif i c se par at ion. De t e c tor s 11 see 11
the various components as they elute and integrators
collect, quantitate and interpret results. Results are
presented as a series of peaks on a chart and retention
time is used to identify unknown components in the
sample (Williams and Wilson, 1984).
Various separation mechanisms are employed in HPLC,
including:
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1) Size separation, which is a form of non-interactive
chromatography i.e. no chemical reaction takes
place within the system. Molecules are instead
separated by a porous gel on the basis of molecular
si ze.
2 ) Ion - e xc hange c'h r 0 mat 0 grap hy, whi chi sus e d for the
separation of substances that are in an ionized
form. The stationary phase consists of a porous
organic or inorganic gel or resin carrying func-
tional groups on its surface. The eluent contains
ions of opposite charge to ions of the stationary
phase. Sample ions exchange places with eluent ions
and remain on the column for a certain period of
time depending on the relative affinity of the
packing for the eluent or sample ions.
3) Liquid-liquid or partition chromatography, where
the column consists of a bed support (usually
inert) on which the stationary partitioning phase
is adsorbed. The mobile phase fl owi ng through the
column is in contact with the stationary phase over
a large interphase. In this process, equilibrium
distributions of the solute between the two phases
take place rapidly. Separation of the different
components of a mixture results from the differing
distributions of the various solutes in these two
unlike phases.
- 80 -
4) Liquid-solid or absorption chromatography, involves
a relatively non-polar liquid mobile phase and a
sol id pol ar stationary phase. Separation of pol ar
molecules occurs between the two phases.
3 .6. 2 • Determination of plasma PLP and PL levels by
HPLC
Plasma pyridoxal-5-phosphate (PLP) content is employed
with increasing frequency as an indicator of the nutri-
tional status of vitamin B-6 (Lawrence et al, 1978). For
the simultaneous quantification of plasma PLP and PL
levels, the method devised by Ubbink et al, 1985/1986
was employed. This simple isocratic technique is a rapid
and sensitive HPLC method that makes use of an internal
standard and is based on post-column semicarbazone
formation of PLP and PL, followed by fluoresence detec-
tion. An important feature of this method is the simul-
taneous addition of trichloroacetic acid (TCA) and semi-
carbazide to plasma to liberate PLP from albumin (Ubbink
et a1, 1986).
Reagents
The internal standard, 6-methyl-2-pyridine carboxal-
dehyde was obtained from Aldrich (Milwaukee, U.S.A.); PL
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and PLP from Merck (Oarmstadt, Germany); Chromatography
grade acetonitrile and all other reagents used
(analytical reagent grade) were also obtained from
Merck.
Purification
The commercial PLP and PL preparations were purified by
reversed-phase HPLC (Whatman Partisil 10 00S-3 column;
mobile phase: 10% methanol and 0.1% glacial acetic acid
in water) and then lyophilized. Ion-pair chromatography
was employed to check for impurities in purified PLP and
PL; UV detection (290 nm) and wavelength scanning
(210-360 nm) at different stages of peak elution. UV
absorption spectra of the purified PLP and PL were
determined in 0.1 M hydrochloric acid, 0.1 M sodium
hydroxide and 0.1 M sodium phosphate buffer at pH 7.0.
Standards
Working standards containing 1-20 ng PLP and PL per ml
were prepared by using purified PLP and PLo Equal
volumes of standard solution and precipitation reagent
(50 ml TCA, 30 ml semicarbazide) were added to labelled




0.5 ml of precipitation reagent was added to an equal
volume of plasma. The mixture was vigorously 'shaken to
ensure even protein precipitation. Before injection, the
sampl es were centri fuged at 4000 rpm for 15 mi nutes.
200 ~l of supernatant from each sample were then
transferred to individual microvials.
Instrumentation
A Beckman (Beckman Instruments, Berkeley, CA, U.S.A.)
Model 112 solvent delivery module was modified so that
the pump was used for solvent delivery. An LS 4
Perkin-Elmer fluorescence pectometer (excitation
wavelength: 367 nm); emission wavelength: 478 nm) was
coupled to a Spectra Physics 4920 integrator (San Jose,
CA, USA).
Columns
A Whatman (C1ifton, NJ, USA) Partisphere C18 analytical
column (110 x 4.7 mm 1.0.; particle size 5 ~m) was used.
A Whatman reversed-phase cartridge was installed between




A solution of 0.05 M potassium dihydrogen phosphate (pH
adjusted to 2.9 by use of concentrated orthophosphoric
acid) containing 4% acetonitrile was used as mobile
phase. Sodium hydroxide (2% w/v) was introduced for
post-column alkalinization. The solvent delivery pump
and the post column reagent pump flow-rates were 1 and
0.1 ml/min respectively.
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3 . 7. Ti s sue ana1y s. i s
3 . 7 . 1 . Sam p1e pr epar a t ion
3.7.1.1. Drying of bones
Prior to wet ashing of tissue samples, the tibias were
dri ed to a constant wei ght. Ti bi as were removed from
refri geration and allowed to thaw. The thawed sampl es
were then blotted dry on ashless paper. The bones were
then individually weighed (wet weight) using plastic
weighing boats on an electronic balance (Mettler BB 300)
and the masses recorded. Tibias were then transferred to
separate 1abelled 20 ml beakers which were then pl aced
in the oven at 110°C for 24 hours. It was determined
that 24 hours was adequate time for the complete drying
of tibia samples. After 24 hours, the samples were
removed from the oven and transferred to a dessi cator
where they remained for approximately 30 minutes unti 1
cool. The dry weights of the tibias were then recorded.
3.7.1.2. Wet ashing
Atomic absorption spectrometry requires that samples be
in a liquid form to enable analysis (Clegg et al, 1981).
A variety of methods exist at present for the
solubilization of biological tissues for atomic
- 85 -
absorption spectrometry. Wet ashing procedures are being
used more extensively because of the increased interest
in the biological role of trace metals. Several methods
of wet ashing were examined by Clegg et al, 1981, to
determine which acids, acid combinations, or bases
should be used as digesting agents for accurate and
precise measurement of iron, copper, zinc and manganese.
It was found that nitric acid proved to be the most
effective wet ashing agent. Nitric acid was therefore
chosen for wet ashing in the present study.
Tibia samples were transferred to labelled 50 ml
Kjeldahl flasks, each containing 5 ml of nitric acid and
three gl ass beads. Sampl es were predi gested for
approximately 12 hours at room temperature. After
predigestion, samples were heated and maintained at a
constant slight boil for 4 hours and then allowed to
cool. Digested samples were subsequently transferred to
50 ml volumetric flasks. The inside of the digestion
flasks were rinsed several times with deionised water to
ensure complete transfer of the acid digest. Samples
were then brought to volume with deionised water (Clegg
et al, 1981).
Digestion was carried out in sets of 6 samples,
comprising 4 tibia samples {one each from groups A, B
and C and one tibia from the control group for recovery
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studies), a blank and a blank plus standard.
3 . 7 .2. Recovery studies
Eleven tibias, one from each of the control group
animals were used for recovery studies. The bones were
dried and wet ashed as described above. A known
concentration of Zn stock standard (Spectrosol, SOH
Chemicals, Poole, England) was then added to the samples
to enable the determination of percentage recoveries so
as to standardize the ashing and atomic absorption
methods.
Note - One of the tibias from each of the group A rats
was used for recovery studi es and the other ti bi a for
determination of Zn levels in the control animals.
3.7.3. Atomic absorption spectrophotometry (AAS)
3.7.3.1. General principles of flame atomic absorption
spectrophotometry (FAAS)
At present, the most widely employed methods to
determine Zn concentrations in biological samples are
based on atomic spectrometry the interaction of
ana1yte atoms with electromagnetic radiation. These
procedures fall into three categories -
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- atomic emission
- atomic absorption and
- atomic fluorescent spectrometry
FA AS (the method used in the present study) is the most
widely used technique for routine analysis of most
elements including zinc (Falchuk et al, 1988).
Briefly, the mechani sm of FAAS may be summarized as
follows: A hollow cathode tube emits a narrow 1ine
spectrum specific for the element to be measured. The
particular wavelength to be employed is isolated by a
monochromator (usually 213.9 nm for Zn). A detection
system converts the radiant energy received into an
electrical signal. In the absence of sample, the readout
is shown as zero percent absorbance or hundred percent
t ran smi t tan c e . A 1i qui d s am p1e ( 1- 2 m1) i sas pi rat ed
into a flame nebulizer system where the sample atoms are
atomi sed. The radi ation emitted by the hollow cathode
tube is absorbed by the sample atoms in proportion to
their concentration. The absorption decreases the
incident radiation received by the detection system. For
most instruments, the proportionality between Zn and
absorbance follows Beers Law and is linear in the range
of 0.1-1.0 ~g Zn/ml.
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Because of the specificity of the line spectra, it is
possible to determine the amounts of a specific element
present. Since the amount of radiation present is
proportional to the number of excited atoms, standard
solutions are used to calibrate the system. The flame
most widely used is the air/acetylene flame (Welz,
1976).
3.7.3.2. Analysis of tibia Zn levels by FAAS
Zinc levels of tibias were determined by FAAS. The
Perkin-Elmer Model 2380 microprocessor controlled atomic
absorption spectrophotometer (Perkin-Elmer Corporation,
Norwalk, C.T., U.S.A.) was used. Results were expressed
in ~g/gram of dry tissue.
Set-up procedure
The hollow cathode lamp specific for Zn was installed
into the lamp compartment as specified by the
instruction manual (Perkin-Elmer, 1976 b) and the lamp
control was adjusted until the lamp current as specified
on the 1amp was reached. A ten mi nute 1amp warm-up.
period was allowed.
The appropriate instrumental settings, as specified for







The gain setting was used to optimize both the
wavelength and lamp current.
Prior to ignition, the air pressure was adjusted to 280
kPa and the acetylene pressure to l40kPa. The air and
acetylene tanks were equipped with pressure regulators
which were regularly checked to ensure that the
pressures remained constant. Ignition resulted in a lean
blue oxidizing air-acetylene flame.
Before sample analysis, deionised water was aspirated
for a few minutes to clear the burner slot of any
contaminants.
Calibration
A Zn working standard was prepared daily from Spectrosol
grade Zn nitrate stock standard having a concentration
of 1000 ~g/ml (BOH Chemicals, Poole, England). To estab-
lish a linear standard curve, a 1 ~g/ml Zn standard was
used. The calibration standard was analysed after three
sample readings were recorded and recalibration was
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performed if the known concentration varied by >5%.











To obtain maximum sensitivity, the burner head and the





When several measurements are taken on the same experi-
mental unit (rat), the measurements tend to be
correlated with each other. When the measurement can be
thought of as responses to levels of an experimental
factor of interest such as time, the correlation can be
taken into account by performing a repeated measures
analysis of variance (used in the present study).
In this analysis, the dependent variable was growth at
day one, week to week 8 after receiving the diet.
Logarithms were applied to the growth to minimize
correlation between the mean and variance of the data.
Individual analysis of variance (ANOVAS) was performed
on the growth at each week (for differences between the
groups at each week). Duncan's multiple range tests were
used for multiple comparisons.
Food consumption
Repeated measures analyses were performed on mean weekly
food consumption and Duncan's multiple range tests were
used for multiple comparisons.
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Zn concentration in rat tibias
The three groups were compared using analysis of
variance with Duncan1s multiple range test.
Plasma PL and PLP levels.
ANOVAS were also performed on PLP and PL levels.
Note: All statistical analyses were done in colla-
boration with Ms E.Gouws (Institute of Biostatistics of
the South African Medical Council) and Professor G.P.Y.
Clarke (University of Natal, Pietermaritzburg,




4.1. The effect of vitamin 8-6 deficiency on food
consumption
The mean weekly food consumption for the rats in groups
A and C, over the eight week period, is shown in table
2. The food consumption of the group C animals was found
to decline significantly from the second week onwards. A
significant difference in the food intake between groups
A and C was observed from weeks two to ei ght (p <0.05).
The pair-fed rats (group B), fed the PN-sufficient diet
in amounts equivalent to the mean weekly intakes of the
deficient animals, were found to consume all of their
food. Their weekly food intake was thus equivalent to
that of the PN-deficient rats.
Two-tailed P values are given in table 3.
Fi gure 12 represents the food consumpt i on trends for
groups A and C.
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Table 2: Effect Of Vitamin 8-6 Deficiency on Weekly Food
Consumption (g).
GRP WEEK 1 WEEK 2 WEEK 3 WEEK 4 WEEK 5 WEEK 6 WEEK 7 WEEK 8
8.29 10.64 12.21 14.66 16.51 15.77 15.36 15.69
A a a a a a a a a
±0.90 ±0.58 ±0.86 ±0.66 ±1 .85 ±2.24 ±2.19 ±1.64
7.99 8.06 7. 71 7. 12 6.58 6.34 6.36 5.97
C a b b b b b b b
±0.57 ±0.39 ±0.26 to.39 to.42 to.44 to.44 to.70
Data are presented as mean tSD and were obtained from 11 rats
per group. Means for each week not followed by the same super-
script letter are significantly different (p <0.05). Groups A
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Table 3: Two-tailed P-values - Effect of vitamin B-6
deficiency on weekly food consumption
GRP WEEK 1 WEEK 2 WEEK 3 WEEK 4 WEEK 5 WEEK 6 WEEK 7 WEEK 8
A
vs 0.3655 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001
C
A significant difference exists between groups if the P
value is < 0.05.
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4.2. The effect of vitamin B-6 deficiency on growth
Data on the mean body mass of the 3 groups of rats are
given in table 4. In table 5, the mean body masses
(given in table 4) are expressed in logarithmic form to
minimize correlation between the mean and variance of
the data.
The mean weights of the rats in all three groups were
simi 1ar at the beginning of the experiment. However, by
the second week a significant difference in mass was
noted between groups A and C and groups A and B
(p <0.05). No significant difference in body weight was
noted between groups Band C (p >0.05). This pattern
continued for the next two weeks as well. By the fifth
week, however, a significant difference in mass was
observed between all three groups. This trend continued
for the duration of the experiment. The difference in
mean body mass between groups A and C was greater than
the difference between groups A and B from the thi rd
week onwards.
Figure 13 shows the growth patterns of the three
different groups.
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Table 4: Effect of vitamin B-6 deficiency on growth (g)
ffiOUP DAY 1 WEEK 1 WEEK 2 WEEK 3 WEEK 4 WEEK 5 WEEK 6 WEEK 7 WEEK 8
A 71.54 88.00 117.09 161.82 199.36 233.36 263.18 289.18 302.09
16.17 ± 8.31 ±1l.13 ±10.23 ±11.99 ±19.45 ±26.65 t34.72 t35.67
B 70.18 85.55 101.91 131.82 151.00 165.64 186.18 192.09 196.36
t7.56 ±12.38 t15.99 t10.79 t14.16 ±14.90 t18.27 t17.39 t16.70
C 72.09 88.91 104.36 127.00 143.45 153.64 168.73 172.18 173.82
±6.63 ±9.75 tl1.5l ±11.69 ± 9.97 tll.29 tll.59 ±12.94 ±13.88
Data are presented as means tSD and were obtained from
11 rats per group. Group A (control group) received 2.42
mg/kg of vitamin B-6 in the diet. Group B is the
pair-fed group. Group C (deficient group) received
o mg/kg of vitamin B-6 in the diet.
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Table 5: Effect of vitamin B-6 deficiency on body mass.
GROUP WEEK 1 WEEK 2 WEEK 3 WEEK 4 WEEK 5 WEEK 6 WEEK 7 WEEK 8
a a a a a a a a
A 4.47 4.76 5.08 5.29 5.45 5.57 5.66 5.70
a b b b b b b b
B 4.44 4.61 4.88 5.01 5. 11 5.22 5.25 5.28
a b b b c c c c
C 4.48 4.64 4.84 4.96 5.03 5.13 5. 15 5. 16
Data are presented as logarithms of mean and were
obtained from eleven rats per group. Values for each
week not followed by the same superscript letter are
significantly different (P <0.05). Group A (control
group) received 2.42 mg/kg of vitamin B-6 in the diet.
Group B is the pair-fed group. Group C received 0 mg/kg
of vitamin B-6 in the diet.
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Figure: 13
4.3. Effect of vitamin B-6 deficiency on plasma PL and
PLP levels
Plasma PL and PLP levels were determined by HPLC at the
end of the eight week experimental period. Duncan l s
Multiple Range Test was employed to determine the
si gni fi cance of difference between groups. There was a
significant difference in both PL and PLP levels between
groups A and C and between groups Band C (P <0.05).
There was no significant difference in PL or PLP levels
between groups A and B.
Table 6 provides the mean PL and PLP values for groups
A, Band C. Figure 14 shows the plasma PL and PLP levels
of the three groups at the end of experimental period.
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Table 6: The effect of vitamin B-6 deficiency on plasma
PL and PLP levels.
Group Plasma PLP ng/ml Plasma PL ng/ml
a a
A 331.70 ± 64.02 202.90 ± 53.13
a a
B 337.00 ± 65.82 227.30 ± 57.23
b b
C 41.50 ± 16.63 21 .50 ± 9.69
Pl asma PL and PLP va 1ues are gi ven as means ± SO and
were obtained from 10 rats in each group. Means for each
group not followed by the same superscript letter are
significantly different (p <0.05). Group A received 2.42
mg/kg of vitamin B-6 in the diet. Group B is the
pai r-fed group and group C recei ved 0 mg/kg of vi tami n
B-6 in the diet. The two-tailed P-va1ues for groups A vs
C and B vs C were equal to 0.0001. A significant
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4.4. Vitamin 8-6 deficiency and tibia Zn levels
Zn levels are expressed in ~g/g dry tissue. Tibia Zn
concentrations were calculated as follows:
Zn concentration in ~g/g
Recovery studies
Zn concentration in ~g/ml x
50 (dilution factor) divided
by the weight of the tissue.
The percentage recovery of Zn from each of the eleven
tibias used was determined after digestion. Individual
values are given in Table 7 and were found to range
between 95 and 101 percent.
Table 7: Percentage of Zn recovered after digestion.















The mean tibia Zn concentrations for groups A, Band C
are given in Table 8.
Group C (deficient animals) were found to have a
significantly lower tibia Zn concentration than groups A
and B (p <0.05). There was no significant difference in
the tibia Zn levels between groups A and B (p )0.05).
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Table 8: Mean of Zn levels in tibias (~g/g).
Group Tibia Zn concentration
a
A 161 . 34 ± 7.78
a
B 159.11 ± 9.07
b
C 141.12 ± 6.02
Values are expressed as means ± SO and were obtained
from 11 rats per group. Means for each group not
followed by the same superscript letter are
significantly different. Group A (control rats) received
2.42 mg/kg of vitamin B-6 in the diet. Group B is the
pair-fed group. Group C (deficient rats) received
o mg/kg of vitamin B-6. The two-tailed P-values for
Groups A vs. C and Groups B vs. C were equal to 0.0001.





5.1. Appearance of rats
The most obvious physical symptom observed in the
vitamin B-6 deficient animals was poor growth which
became apparent from the second week onwards. By the
fourth week, some of the rats in the deficient group
showed signs of acrodynia (symmetrical scaling
dermatiti s) on the chin and upper thorax. Al so
noticeable on all deficient rats was the unkempt
appearance of the fur when compared to control rats.
These symptoms are in keeping with the vitamin B-6
deficiency symptoms observed by Rutishauser, 1972 and
Labadarios and Shephard, 1985.
5.2. Food consumption and growth
The vitamin B-6 deficient rats (group C) consumed
approximately 7g of food per day while the control
animals consumed almost twice this amount per day
(13.7g/d). This would in itself account for the signi-
ficant difference in body mass observed between group A
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(control) rats and the PN-deficient animals. However,
the pair-fed rats (group B) also consumed only 7g/d and
yet showed a significantly higher growth rate than the
deficient group from the fifth week onwards. This would
suggest that the decreased growth rate of the deficient
rats was due largely to a factor other than the
decreased caloric intake.
The deficient group received no pyridoxine in their diet
while the control and pair-fed rats received 33 ~g/d and
17 ~g/d of pyridoxine respectively. The significant
difference in growth rates observed between groups C and
B from the fifth week onwards can therefore be
attributed to a deficiency of pyridoxine in the group C
animals, since both groups consumed the same amount of
food. The significant difference in growth rates between
group A and group C rats from the second week onwards is
therefore due primari ly to a pyridoxine deficiency in
group C animals, although a decreased caloric intake is
also a contributory factor.
The significant difference in growth between groups A
and B can also be accounted for by pyridoxine levels.
Group B rats consumed only 17 ~g/d of pyridoxi ne whi 1e




A survey of the literature reveals that the vitamin B-6
requirement for rats as reported by individual inves-
tigators ranges from between 24 ~g/d to 80 ~g/d. Lumeng
et al, 1987 found that maximal growth occurred in wean-
ling rats receiving 29 ~g/d of PN.HC1, while Van den
Berg et al, 1982 reported that 24 ~g/d of pyridoxine is
required to produce maximal growth in rats. Other
researchers have reported hi gher level s of pyridoxi ne
(75 ~g/d) as being necessary for optimal growth in rats
(Mercer et al, 1984).
The above fi ndi ngs suggest that the pai r-fed group in
the present study received less pyridoxine than is
required to allow maximal growth. This would explain the
significant difference in body weights between the
control and pair-fed rats in this study.
The various observations in the present study with
regard to food consumption and growth suggests that both
a decreased caloric intake and PN deficiency account for
the decreased growth rats of group C and B rats when
compared to group A animals; however since the signi-
ficance of difference between groups A and C is greater
than that between groups A and B, one can concl ude that
pyridoxine deficiency is the major contributory factor
resulting in the decreased growth rates observed.
- 11 0 -
5.3. Plasma PL and PLP levels
Plasma PL and PLP levels were measured by a HPLC
technique developed by Ubbink et al, 1985. The purpose
of this analysis was to establish whether there was a
significant difference in the levels of plasma PL and
PLP between the deficient rates (group C) and the
control rats (group A).
The levels of plasma PL and PLP in all three groups were
higher than values reported in the literature for
control and vitamin B-6 deficient rats (Channa, 1988).
No explanation can be given at present for this obser-
vation.
The deficient rats were, however, found to have signi-
ficantly lower plasma PL and PLP levels than the control
and pair-fed animals. The plasma PLP and PL levels in
the deficient animals were approximately eight and nine
times lower than that in the control animals, respec-
tively.
5.4. Tibia Zn concentrations
The vitamin B-6 deficient rats were observed to have
significantly lower tibia zinc concentrations than the
control and pair-fed animals. No significant difference
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in tibia Zn concentrations was found between pair-fed
and cont ro 1 rat s.
These observations are in keeping with reports by Hsu,
1965 and Ikeda et al, 1979 who maintained that a vitamin
B-6 deficiency results in decreased Zn levels in various
tissues. Since there was no significant difference in
tibia Zn levels between control and pair-fed animals, it
can be concluded that the decreased zinc levels observed
in the deficient group is due to a vitamin B-6
deficiency and not to the decreased caloric intake of
the group.
The findings in the present study may be explained by
the observations of Evans and Johnson, 1981, who
reported an impairment of Zn absorption resulting from a
vitamin B-6 deficiency. The decreased Zn absorption was
attributed to a decreased producti~n of a low molecular
weight Zn-binding ligand viz. picolinic acid. Picolinic
acid is a product of tryptophan metabolism and pyridoxal
is an essential cofactor in the pathway from tryptophan
to picolinic acid. A decrease in vitamin B-6 would
therefore result in a decreased production of picolinic
acid which in turn would result in decreased Zn absorp-
tion leading to decreased tissue zinc levels.
The observations in the present study are thus in
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keepi ng wi th fi ndi ngs by Brown, 1985, who stated that
the nutritional status of zinc is related to vitamin B-6
status.
5.5. Zinc bioavailability as affected by a vitamin B-6
deficiency
The bioavailability of zinc may be defined as that
proportion of dietary Zn which is absorbed and utilized
in Zn metabolism (Schaafma et al, 1988). Tibia Zn levels
and growth were chosen as parameters to assess Zn
bioavailability as affected by vitamin B-6 deficiency in
this study.
A vitamin B-6 deficiency was found to result in
decreased tibia Zn levels indicating a decreased bio-
availability of zinc. One might however argue that
vitamin B-6 was not the only 1imiting nutrient in the
deficient rats (group C) since their daily food intake
was approximately half that of the control animals. This
woul d mean that the decreased ti bi a Zn 1evel s observed
in the present study may be due not only to the vitamin
B-6 deficiency but also to the decreased caloric intake.
The tibia Zn levels observed in the pair-fed group do,
however, show that the decreased caloric intake did not
affect tibia Zn levels. The mean tibia Zn levels between
the control and pair-fed animals showed no significant
- 113 -
difference indicating that the caloric intake in the
present study was not a 1imiting factor with regard to
tibia Zn concentrations. From this, it can safely be
concluded that the reduced tibia Zn levels of the
defi ci ent group are in fact due to vi tami n B-6 defi-
ciency.
Rosenberg and Solomons, 1982 have roughly divided
factors that influence the bioavailability of tr.ace
e 1em en t sin tot h0 sew hi chi nflu en ce be havi 0 ur i nth e
intestinal lumen and those which occur at the level of
the intestinal cell.
In the present study, the influence of vitamin B-6 defi-
c i en cy 0 n t i bi a Zn con cent rat ion s may bet r ace d tot he
absorptive level, that is, at the level of the
intestinal lumen. The decreased bioavai1abi1ity of Zn as
a result of vitamin B-6 deficiency can thus be accounted
for by the influence of vitamin B-6 on Zn absorption.
Evans et a1, 1979 provided evidence suggesting that the
dominant Zn-binding ligand in the rat intestine is
picolinic acid. Picolinic acid has been shown to
facilitate Zn absorption (Evans, 1980) by forming
dipicolinate complexes with Zn 2+. Evans and Johnson,
1981 showed that a deficiency of pico1inic acid impairs
Zn absorption.
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Since PA is a product of pyridoxine-dependent tryptophan
metabolism, a deficiency of either pyridoxine or tryp-
tophan would impair Zn absorption. Therefore, in the
present study it can be hypothesi sed that the vi tami n
B-6 deficiency resulted in a decrease in the synthesis
of picolinic acid. Pyridoxal is required as a cofactor
for the enzyme kynureninase in the pathway from
tryptophan to PA. The decreased synthesis of PA would
result in a malabsorption of Zn which would account for
the decreased levels of Zn observed in the tibias of the
vitamin B-6 deficient rats.
The decreased tibia Zn concentrations in the vitamin B-6
de f i c i en t rat s may bed ue not 0 n1y tot he de crea sed
uptake of Zn at the absorptive level, but also as a
result of Zn mobilization from bone during a zinc
deficiency state. This would be i n keeping with the
findings of Calhoun et a1, 1978 who reported signi-
ficantly lower Zn levels in zinc deficient rats when
compared to control animals. It was suggested that zinc
is not "locked" in the bone in young animals but rather
that the bone serves as a Zn store from which Zn may be
mobilized during a deficiency state. These observations,
however, still strongly point to an impaired Zn
absorption which would result in zinc mobilization from
bone.
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It must be mentioned, however, that the involvement of
picolinic acid in Zn absorption as suggested by Evans et
al, 1979 has not as yet been conclusively demonstrated.
Hurley and Lonnerdal have cast doubt on the involvement
of picolinic acid in Zn absorption. They maintained that
the effects of picolinic acid with regard to Zn
absorption are not unique since other Zn-binding ligands
are also present in the intestinal mucosa.
Although the exact mechanism whereby Zn absorption i s
affected by a vitamin B-6 deficiency may not be known at
present, the findings i n the present study do however
suggest that a vitamin B-6 deficiency does have an
effect on the Zn absorption i n rats.
In addition to decreased tibia Zn levels, the vitamin
B-6 deficient rats also showed significantly lower
growth rates when compared to control animals. The
growth pattern by itself may not, however, enable one to
conclude that vitamin B-6 has an effect on Zn bioavail-
ability since the caloric intake of the deficient rats
was significantly lower than that of the control
animals. However, as already discussed, the significant
difference in body wei ghts between pa i r-fed and
deficient animals in the second half of the experimental
period would suggest that vitamin B-6 deficiency does
- 116 -
reduce the growth Tates of the deficient rats.
Both the decreased tibia Zn concentrations and the
decreased growth rates in the vitamin B-6 deficient rats
when compared to control and pair-fed animals would
suggest that a vitamin B-6 deficiency does indeed lower




The results of this study point to a significant
difference in the bioavailability of zinc between
animals that receive adequate amounts of vitamin B-6 and
animals that are deficient in vitamin B-6.
Both tibia Zn concentration and animal growth were found
to be significantly lower in the vitamin B-6 deficient
rats than the control animals, indicating a decreased
bioavailability of Zn in response to a vitamin B-6
deficiency. The influence of vitamin B-6 on zinc
bioavailability has been traced to the absorptive level
of zinc. As already discussed, various studies have
provided evidence which suggest that the dominant
Zn-binding ligand in the rat intestine is picolinic
acid, a product of pyridoxine-dependent tryptophan
metabolism (Evans et al, 1979). The decreased zinc
bioavailability observed in the present study has been
attributed to a decrease in picolinic acid which results
from a vitamin B-6 deficiency.
The findings in this study also support the suggestion
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that bone serves as a zi nc store from whi ch Zn is
mobilized during a Zn deficiency state (Calhourn et al,
1978). This would mean that bone Zn concentration may be
employed as a parameter to determine Zn bioavailability
in rats.
The exact mechanism whereby vitamin B-6 deficiency
affects zinc bioavailability is incompletely understood
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Various studies have shown that both zinc and vitamin
B-6 participate in a great variety of enzymatic
reactions. A deficiency of vitamin B-6 has been observed
to affect tissue zinc levels in rats. The present study
was undertaken to determine the effect of a vitamin B-6
deficiency on the bioavailability of zinc in the rat.
Tibia Zn levels and animal growth were used as
parameters to assess Zn bioavailability.
Thirty-three young male Wistar rats were divided into
three groups of eleven rats each. Group A, the control
animals, received 2.42 mg PN.HC1/kg of diet. Group B,
the control pair-fed rats, received the same diet as
group A but their rations were restricted to the amounts
consumed by the deficient rats. Group C, the vitamin B-6
deficient rats, received a vitamin B-6 deficient diet.
Plasma PL and PLP levels were determined to establish
the vitamin B-6 status of each rat. A significant
difference in PL and PLP levels was observed between the
deficient and control rats.
Ti bi a Zn 1evel s were determi ned by




deficient animals were found to be significantly lower
than tibia zinc concentrations of the control and
pair-fed rats. The low tibia zinc levels of the
deficient animals were attributed to a decrease in the
concentration of picolinic acid. Picolinic acid, a
product of pyridoxine-dependent tryptophan metabol ism,
is reported to be a major Zn-binding ligand in the rat
intestine.
The food consumption and growth rates of the deficient
group were found to be significantly lower than the
control group.
These findings would suggest that the bioavailability of
zinc is lowered during a vitamin B-6 deficiency in rats.
- 122 -
REFERENCES
Aggett, P.J., 1985. Physiology and metabolism of
essential trace elements: An outline. Clinics in
Endocrinology and Metabolism 14 : 513-543.
Aggett, P.J., 1989. Severe zinc deficiency, p.259-280.
In: Mills, C.F. (ed), Zinc in human biology,
Springer-Verlag, Berlin Heidelberg.
Baer, M.T. and King, J.C., 1984. Tissue zinc levels and
zinc excretion during experimental zinc depletion in
young men. Am. J. Clin. Nutr. 39 : 556-570.
Brown, E.D., Chan, W. and Smith, J.C., 1978.
Bone mineralization during a developing zinc deficiency.
Proc. Soc. Exp. Biol. Med. 157 : 211-214.
Brown, R.R., 1981. The tryptophan load test as an index
of vitamin B-6 nutrition, p.32l-340. In: Leklem, J.E.
and Reynolds, R.D. (eds), Methods in vitamin B-6
nutrition: Analysis and status assessment, Plenum
press, New York.
- 123 -
Brown, R.R., 1985 .. Possible roles for vitamin 8-6 and
trace elements in health and disease, p.48l-489.
~: Reynolds, R.D. and Leklem, J.E. (eds), Current
topics in nutrition and disease, Vol 13. Vitamin B-6:
Its role in health and disease, Alan R. Liss, New York.
Calhoun, N.R., MacDaniel, E.G., Howard, M.P. and
Smith, J.C. Jr, 1978. Loss of zinc from bone during
deficiency state. Nutr. Rep. Intl. 17 : 299-306.
Calhoun, N.R., Smith, J.C. Jr, Kenneth, L. and
Becker, M.D., 1974. The role of zinc in bone metabolism.
Clinical Orthopaedics and Related Research 103 :
212-234.
Channa, M.L., 1988. M.Sc. Thesis: The effect of vitamin
B-6 deficiency on copper, zinc and iron balance in the
rat, University of Durban-Westville, Durban.
Chesters, J.K., 1982. Metabolism and biochemistry of
zinc, p.221-238. ~: Clinical, biochemical and
nutritional aspects of trace elements, Alan R. Liss, New
York.
Chesters, J.K. and Will, M., 1981. Zinc transport
proteins in plasma. Br. J. Nutr. 46 : 111-118.
- 124 -
Clegg, M.S., Keen,. C.L. and Hurley, L.S., 1989.
Biochemical pathologies of zinc deficiency, p.129-l46.
In: Mills, C.F. (ed), Zinc in human biology,
Springer-Verlag, Berlin Heidelberg.
Clegg, M.S., Keen, C.L., Lonnerdal, B. and Hurley, L.S.,
1981. Influence of ashing techniques in the analysis of
trace elements in animal tissue. Biological Trace
Element Research 3 : 107-115.
Cousins, R.J., 1979. Regulation of zinc absorption:
Role of intracellular ligands. Am. J. Clin. Nutr. 32
339-345.
Cousins, R.J., 1985. Absorption, transport and hepatic
metabolism of copper and zinc: Special reference to
metallothionein and ceruloplasmin. Physiological Reviews
65 : 238-309.
Cousins, R.J., 1989. Systemic transport of zinc,
p.79-94. ~: Mills, C.F. (ed), Zinc in human biology,
Springer-Verlag, Berlin Heidelberg.
Cuthbertson, W.F.J., 1957. A typical rat diet. Nutr.
Soc. Proc. 16 : 70.
- 125 -
Dakshinamurti, K. and Paulose, C.S., 1988. Central
nervous system origin of hypertension in the vitamin B-6
deficient adult rat, p.159-175. ~: Leklem, J.E. and
Reynolds, R.D. (eds), Current topics in nutrition and
disease, Vol 19. Clinical and physiological applications
of vitamin B-6, Alan R. Liss, New York.
Dangi, P. and Kapoor, A.C., 1983. Assessment of zinc
status in rats. Indian Journal of Experimental Biology
21 : 680-683.
Davies, N.T., 1980. Studies on the absorption of zinc by
rat intestine. Br. J. Nutr. 43 : 189-203.
Doyle, M.P. and Mungall, W.S. (eds), 1980.
Observing chemical reactions: Solubility tests,
chemical characterization tests, and thin layer
chromatography, p.81-94. ~: Experimental Organic
Chemistry, John Wiley and Sons, New York.
Driskell, J.A., 1984. Vitamin B-6, p.379-400.
~: Lawrence, J.M. (ed), Handbook of vitamins
Nutritional, biochemical and clinical aspects, Marcel
Dekker, New York.
- 126 -
Evans, G.W., 1980 .. Normal and abnormal zinc absorption
in man and animals: The tryptophan connection. Nutr.
Rev. 38 : 295-296.
Evans, G.W., Grace, C.l. and Votava, H.l., 1975. A
proposed mechanism for zinc absorption in the rat.
Am. J. Physio1, 228 : 501-505.
Evans, G.W. and Johnson, E.C., 1980. Zinc absorption in
rats fed a low protein diet and a low protein diet
supplemented with tryptophan or pico1inic acid. J. Nutr.
110 : 1076.
Evans, G.W. and Johnson, E.C., 1981. Effect of iron,
vitamin B-6 and pico1inic acid on zinc absorption in the
rat. J. Nutr. 111 : 68-75.
Evans, G.W., Johnson, E.C., Brushmiller, J.G. and Ames,
R.W., 1979. Detection of labile zinc binding ligands in
biological fluids by modified gel filtration
chromatography. Anal. Chem. 51 : 839-843.
Falchuk, K.H., Hilt, K.l. and Vallee, B.l., 1988.
Determination of zinc in biological samples by atomic
absorption spectrometry. Methods in Enzymology 158 :
422-434.
- 127 -
Fitzgerald, F.T. and Tierney, L.M. Jr, 1984.
Trace metals in human disease. Adv. Internal. Med. 30
337-358.
Forbes, R.M. and Parker, H.M., 1977. Biological
availability of zinc in and as influenced by whole fat
soy flour in rat diets. Nutr. Rep. Intl. 15 : 681-688.
French, S.W., 1966. Effect of chronic ethanol ingestion
on liver enzyme changes induced by thiamine, riboflavin,
pyridoxine or choline deficiency. J. Nutr. 88 : 291-302.
Gershoff, S.N., 1967. Effects of vitamin B-6 and B-1
deficiencies and restricted caloric intake on tissue
zinc levels. P.S.E.B.M. 127 : 1207-1210.
Giugliano, R. and Millward, D.J., 1984. Growth and zinc
homeostasis in the severely zinc-deficient rat. Br.J.
Nutr. 52 : 545-560.
Golden, B.E., 1989. Zinc in cell division and tissue
growth: Physiological aspects, p.119-l28. ~: Mills,
C.F. (ed), Zinc in human biology, Springer-Verlag,
Berlin Heidelberg.
- 128 -
Gold en, M. H. N., 198 9. The di agnos i s 0 f z i nc def i c i ency ,
p.323-334. ~: Mills, C.F. (ed), Zinc in human biology,
Springer-Verlag, Berlin Heidelberg.
Hahn, C. and Evans, G.W., 1973. Identification of a low
molecular weight 65 Zn complex in rat intestine. Proc.
Soc. Exp. Biol. Med. 144: 793.
Hallmans, G., Nilson, U., Sjostrom, R., Wetter, L. and
Wing, K., 1987. The importance of the body's need for
zinc in determining zinc availability in food: A
principle demonstrated in the rat. Br. J. Nutr. 58
59-64.
Halsted, J.A., Smith, J.C. Jr, and Irwin, M.I., 1974.
A conspectus of research on zinc requirements of man.
J. Nutr. 104 : 346-378.
Henderson, L.M., 1985. Intestinal absorption of vitamin
B-6 vitamers, p.25-33. In: Reynolds, R.D. and Leklem,
J.E. (eds), Current topics in nutrition and disease, Vol
13. Vitamin B-6: Its role in health and disease, Alan R.
Liss, New York.
- 129 -
Hove, E., E1vehjem, C.A. and Hart, E.B., 1938. Further
studies on zinc deficiency in rats. Am. J. Physio1.
124 : 750.
Hsu, J.M., 1965. Zinc content in tissues of pyridoxine
deficient rats. Proc. Soc. Expt1. Bio1. Med. 119 :
177-180.
Hurley, L.S., 1981. Teratogenesis of trace element
deficiency. Br. J. Nutr. 61 : 257-274.
Hurley, L.S. and Lonnerda1, B., 1980. Tryptophan,
pico1inic acid and zinc absorption: An unconvincing
case. Nutr. Rev. 38 : 2536-2538.
Hurley, L.S. and Lonnerda1, B., 1980. Zinc absorption
and tryptophan metabolism. Nutr. Rev. 38 : 295.
Ikeda, M., Hosotani, T., Ueda, T., Kotake, Y. and
Sakakibara, B., 1979. Observation of the concentration
of zinc and iron in tissues of vitamin B-6 deficient
germ-free rats. J. Nutr. Sci. Vitamino1 25 : 151-158.
Ink, S.L., 1984. Vitamin B-6 metabolism. Ann. Rev. Nutr.
4 : 455-470.
- 130 -
Jackson, M.J., 1989. Physiology of zinc: General
aspects, p.1-14. ~: Mills, C.F. (ed), Zinc in human
biology, Springer-Verlag, Berlin Heidelberg.
Jackson, M.J., Jones, D.A. and Edwards, R.H.T., 1981.
Zinc absorption in the rat. Br. J. Nutr. 46 : 15-27.
Jackson, M.J., Jones, D.A., Edwards, R.H.T., Swainbank,
I.G. and Coleman, M.L., 1984. Zinc homeostasis in man:
Studies using a new stable isotope dilution technique.
Br. J. Nutr. 51 : 199-208.
Kandutsch, A.A. and Baumann, C.A., 1953. Factors
affecting the stability of thiamine in a typical
laboratory diet. J. Nutr. 49 : 209.
Krieger, I. and Statter, M., 1987. Tryptophan deficiency
and picolinic acid: Effect of zinc metabolism and
clinical manifestations of pellagra. Am.J. Clin. Nutr.
46: 511-517.
Labadarios, D. and Shephard, G.S., 1985. Vitamin B-6 :
Use and deficiencies in clinical practice. Tydskrif vir
Dieet en Huishoudkunde 13 : 22-24.
- 131 -
Law r ence, L., Ry an, .M. P. and Li, T., 1978. Va 1i dat ion 0 f
the diagnostic value of plasma pyridoxal-5-phosphate
measurement in vitamin B-6 nutrition of the rat. J.
Nutr. 108 : 545-553.
Leklem, J.E., 1988. Vitamin B-6 metabolism and function
in humans, p.3-28, ~: Leklem, J.E. and Reynolds, R.D.
(eds), Current topics in nutrition and disease, Vol. 19.
Clinical and physiological applications of vitamin B-6,
Alan R. Liss, New York.
Litwack, G., Miller-Diener, A., Disorbo, D.M. and
Schmidt, T.J., 1985. Vitamin B-6 and the glucocorticoid
receptor, p.177-l9l. In: Reynolds, R.D. and Leklem, J.E.
(eds), Vitamin B-6 : Its role in health and disease,
Alan R. Liss, New York.
Lonnerdal, B., 1989. Intestinal absorption of zinc,
p.33-56. ~: Mills, C.F. (ed), Zinc in human biology,
Springer-Verlag, Berlin Heidelberg.
Lonnerdal, B., Cederblad, A., Davidsson, L. and
Sandstrom, B., 1984. The effect of individual components
of soy formula and cows' milk formula on zinc
bioavailability. Am. J. Clin. Nutr. 40 : 1064-1070.
- 132 -
Lonnerdal, B., Stanislowski, A.G. and Hurley, L.S.,
1980. Isolation of a low molecular weight zinc binding
ligand from human milk. J. Inorg. Biochem. 12 : 71-78.
Lumeng, L., Ryan, M.P. and Li, T.K., 1987. Validation of
the diagnostic value of plasma pyridoxal-5-phosphate
measurement in vitamin B-6 nutrition of the rat. J.
Nutr. 108 : 545-553.
Menard, M.P. and Cousins, R.J., 1983. Zinc transport by
brush border membrane vesicles from rat intestine.
J. Nutr. 113 : 1434-1442.
Mercer, P.L., Gustafson, J.M., Higbee, P.T., Geno, C.E.,
Schweisthal, M.R. and Cole, T.B., 1984. Control of
physiological responses in the rat by dietary nutrient
concentration. J. Nutr. 114 : 144-152.
Mills, C.F., 1989. The biological significance of zinc
for man: Problems and prospects, P.37l-381. In: Mills,
C.F. (ed), Zinc in human biology, Springer-Verlag,
Berlin Heidelberg.
Momci lovic, B., Belonje, B., Giroux, A. and Shah, B.G.,
1975. Total femur zinc as the parameter of choice for a
- 133 -
zinc bioassay in rats. Nutr. Rep. Intl. 12 197-203.
Oberleas, D. and Prasad, A.S., 1969. Growth as affected
by zinc and protein nutrition. Am. J. Clin. Nutr. 22 :
1304.
O:Dell, B.L., 1984. Bioavailability of trace elements.
Nutr. Rev. 42 : 301-307.
OIDell, B.L., 1969. Effect of dietary components upon
zinc availability. Am. J. Clin. Nutr. 22 : 1315-1322.
OIDell, B.L., Burpo, C.E. and Savage, J.E., 1972.
Evaluation of zinc availability in foodstuffs of plant
and animal origin. J. Nutr. 102 : 653-660.
Peereboom, J.W.C., 1985. General aspects of trace
elements and health. The Science of the Total
Environment 42 : 1-27.
Perkin E1mer, 1976a. Manual for atomic absorption
spectrophotometry - Model 2380.
Perkin E1mer, 1976b. Analytical methods for atomic
absorption spectrophotometry.
- 134 -
Prasad, R., Lyall, V. and Nath, R., 1982. Effect of
vitamin B-6 and B-1 deficiencies on the intestinal
uptake of calcium, zinc and cadmium. Ann. Nutr. Metab.
26 : 324-330.
Prohaska; J.R., 1987. Trace elements and the brain.
Nutr. Rev. 67 : 886-895.
Richards, M.P. and Cousins, R.J., 1977. Isolation of an
intestinal metallothionein induced by parenteral zinc.
Biochem. Biophys. Res. Commun. 75 : 286-294.
Rosenberg, H.I. and Solomons, N.W., 1982.
Biological availability of minerals and trace elements:
A nutritional overview. Am. J. C1in. Nutr. 35 : 781-782.
Rutishauser, I.H.E., 1982. Vitamin 8-6. Journal of Food
and Nutrition 39 : 158-167.
Sandstead, H.H., 1982. Availability of zinc and its
requirements in human subjects, p.83-101. In: Clinical,
biochemical and nutritional aspects of trace elements,
A1an R. Liss, New York.
- 135 -
Sauberlich, H.E., 1985. Interaction of vitamin 8-6 with
other nutrients, p.193-2l7. ~: Reynolds, R.D. and
Leklem, J.E. (eds), Current topics in nutrition and
disease, Vol 13. Vitamin B-6: Its role in health and
disease, Alan R. Liss, New York.
Sauberlich, H.E., Canham, J.E., Baker, E.M., Raica, N.
Jr and Herman, Y.F., 1972. Biochemical assessment of the
nutritional status of vitamin B-6 in the human. Am. J.
Clin. Nutr. 25 : 629-642.
Schaafma, G., Dekker, P.R. and de Waard, H., 1988.
Nutritional reports of yogurt. Bioavailability of
essential minerals and trace elements. Neth. Milk Dairy
J. 42 : 135-146.
Schricker, F.J. and Forbes, R.M., 1978. Studies on the
chemical nature of a low molecular weight zinc binding
ligand in rat intestine. Nutr. Rep. Intl. 18 : 159.
Shideler, C.E., 1983. Vitamin B-6: An Overview. Focus
49 : 17-22.
Smith, K.T. and Cousins, R.J., 1980. Quantitative
aspects of zinc absorption by isolated, vascularly
perfused rat intestine. J. Nutr. 110 : 316-324.
- 136 -
Smith, K.T., Failla, M.L. and Cousins, R.J., 1979.
Identification of albumin as the plasma carrier for zinc
absorption by perfused rat intestine. Biochem. J. 184 :
627-633.
Solomons, N.W., 1982. Biological availability of zinc in
humans. Am. J. Clin. Nutr. 35 : 1048-1075.
Stryer, L. (ed), 1975. Biosynthesis of amino acids and
heme, p.594. In: Biochemistry, Freeman, W.H. and
Company, New York.
Stuart, S.M., Kelelson, S.M., Weaver, C.M. and Erdman,
J.W. Jr, 1986. Bioavailability of zinc to rats as
affected by protein source and previous dietary intake.
J. Nutr. 116 : 1423-1431.
Swenerton, H. and Hurley, L.S., 1967. Severe zinc
deficiency in male and female rats. J. Nutr. 95 : 8-18.
Ubbink, J.B., Serfontein, W.J. and de Villiers, L.S.,
1985. Stability of pyridoxal-5-phosphate semicarbazone:
Applications in plasma vitamin B-6 analysis and
population surveys of vitamin B-6 nutritional status.
Journal of Chromatography 342 : 277-284.
- 137 -
Ubbink, J.B., Serfontein, W.J. and de Villiers, L.S.,
1986. Analytical recovery of protein-bound
pyridoxal-5-phosphate in plasma analysis. Journal of
Chromatography 375 : 399-404.
Van den'Berg, H., Bogaards, J.J.P., Sinkeldam, E.J. and
Schreurs, W.H.P., 1982. Effect of different levels of
vitamin B-6 in the diet of rats on the content of
pyridoxamine-5-phosphate and pyridoxal-5-phosphate in
the liver. Internat. J. Vit. res. 52 : 407-416.
Welz, B., 1976. Atomic absorption spectroscopy. Verlag
Chemic, Weinheim, New York.
Williams, B.L. and Wilson, K. (eds), 1984. A biologists
guide to principles and techniques of practical
biochemistry, p.72-l26. Edward Arnold, 2nd ed.
Williams, R.B. and Mills, C.F., 1970. The experimental
production of zinc deficiency in the rat. Br. J. Nutr.
24 : 989.
Williams, R.J.P., 1989. An introduction to the
biochemistry of zinc, p. 15-31. ~: Mills, C.F. (ed),
Zinc in human biology, Springer-Verlag, Berlin
Heidelberg.
- 138 -
